Profiles Header - Harvard Catalyst Profiles Header – Harvard Catalyst

Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Roland Baron, Ph.D., D.D.S.

Title
Institution
Department
Address
Phone
Fax
Other Positions
Title
Institution
Department
Title
Institution
Department

Biography
1972 - 1972
Silver Medal, Thesis Prize for the Ph.D. Thesis
1993 - 2003
Merit Award
1997 - 1997
Seymour J, Kreshover Lecture Award
2002 - 2002
Doctor Honoris Causa
2002 - 2002
Japan Society for Promotion of Science Travel Grant
2002 - 2002
Louis V, Avioli Founders Award
2005 - 2005
D. Harold Copp Award in Basic Research

Mentoring
The Role of Insulin of Bone Growth, and the Relation to DeltaFosB/AP1
Summer, 06/20/11 - 08/12/11

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. R01AR064724 (BARON, ROLAND E) May 1, 2014 - Apr 30, 2019
    NIH/NIAMS
    R-Spondin3 as a target for anabolic bone therapy
    Role: Principal Investigator
  2. R01AR062054 (BARON, ROLAND E) Sep 1, 2012 - Aug 31, 2017
    NIH/NIAMS
    Mechanisms and function of the microtubule podosome connection in osteoclasts
    Role: Principal Investigator
  3. R01AG040222 (BARON, ROLAND E) Aug 15, 2011 - Jul 31, 2016
    NIH/NIA
    AP1-dependent regulation of bone mass and energy expenditure in the hypothalamus
    Role: Principal Investigator
  4. R01AR057769 (BARON, ROLAND E) Sep 10, 2010 - Jun 30, 2015
    NIH/NIAMS
    Role of Zfp521 in bone formation and anabolic responses
    Role: Principal Investigator
  5. R01AR054450 (BARON, ROLAND E) Feb 1, 2007 - Jan 31, 2013
    NIH/NIAMS
    From Adhesion to Bone Resorption: The role of Dynamin in Osteoclasts
    Role: Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Chandler H, Lanske B, Varela A, Guillot M, Boyer M, Brown J, Pierce A, Ominsky M, Mitlak B, Baron R, Kostenuik P, Hattersley G. Abaloparatide, a novel osteoanabolic PTHrP analog, increases cortical and trabecular bone mass and architecture in orchiectomized rats by increasing bone formation without increasing bone resorption. Bone. 2018 Oct 19; 120:148-155. PMID: 30343166.
    View in: PubMed
  2. Fulzele K, Dedic C, Lai F, Bouxsein M, Lotinun S, Baron R, Divieti Pajevic P. Loss of Gsa in osteocytes leads to osteopenia due to sclerostin induced suppression of osteoblast activity. Bone. 2018 Dec; 117:138-148. PMID: 30266511.
    View in: PubMed
  3. Roca-Ayats N, Ng PY, Garcia-Giralt N, Falcó-Mascaró M, Cozar M, Abril JF, Quesada Gómez JM, Prieto-Alhambra D, Nogués X, Dunford JE, Russell RG, Baron R, Grinberg D, Balcells S, Díez-Pérez A. Functional Characterization of a GGPPS Variant Identified in Atypical Femoral Fracture Patients and Delineation of the Role of GGPPS in Bone-Relevant Cell Types. J Bone Miner Res. 2018 Sep 05. PMID: 30184270.
    View in: PubMed
  4. Kota SK, Roening C, Patel N, Kota SB, Baron R. PRMT5 inhibition promotes osteogenic differentiation of mesenchymal stromal cells and represses basal interferon stimulated gene expression. Bone. 2018 Dec; 117:37-46. PMID: 30189247.
    View in: PubMed
  5. Idelevich A, Baron R. Brain to bone: What is the contribution of the brain to skeletal homeostasis? Bone. 2018 Oct; 115:31-42. PMID: 29777919.
    View in: PubMed
  6. Idelevich A, Sato K, Nagano K, Rowe G, Gori F, Baron R. Neuronal hypothalamic regulation of body metabolism and bone density is galanin dependent. J Clin Invest. 2018 Jun 01; 128(6):2626-2641. PMID: 29596063.
    View in: PubMed
  7. Baron R, Gori F. Targeting WNT signaling in the treatment of osteoporosis. Curr Opin Pharmacol. 2018 Jun; 40:134-141. PMID: 29753194.
    View in: PubMed
  8. Matsubara T, Kokabu S, Nakatomi C, Kinbara M, Maeda T, Yoshizawa M, Yasuda H, Takano-Yamamoto T, Baron R, Jimi E. The Actin-Binding Protein PPP1r18 Regulates Maturation, Actin Organization, and Bone Resorption Activity of Osteoclasts. Mol Cell Biol. 2018 Feb 15; 38(4). PMID: 29158294.
    View in: PubMed
  9. Bornstein S, Moschetta M, Kawano Y, Sacco A, Huynh D, Brooks D, Manier S, Fairfield H, Falank C, Roccaro AM, Nagano K, Baron R, Bouxein M, Vary C, Ghobrial IM, Rosen CJ, Reagan MR. Metformin Affects Cortical Bone Mass and Marrow Adiposity in Diet-Induced Obesity in Male Mice. Endocrinology. 2017 10 01; 158(10):3369-3385. PMID: 28977604.
    View in: PubMed
  10. Le PT, Bishop KA, Maridas DE, Motyl KJ, Brooks DJ, Nagano K, Baron R, Bouxsein ML, Rosen CJ. Spontaneous mutation of Dock7 results in lower trabecular bone mass and impaired periosteal expansion in aged female Misty mice. Bone. 2017 Dec; 105:103-114. PMID: 28821457.
    View in: PubMed
  11. Motyl KJ, Beauchemin M, Barlow D, Le PT, Nagano K, Treyball A, Contractor A, Baron R, Rosen CJ, Houseknecht KL. A novel role for dopamine signaling in the pathogenesis of bone loss from the atypical antipsychotic drug risperidone in female mice. Bone. 2017 Oct; 103:168-176. PMID: 28689816.
    View in: PubMed
  12. Komaba H, Kaludjerovic J, Hu DZ, Nagano K, Amano K, Ide N, Sato T, Densmore MJ, Hanai JI, Olauson H, Bellido T, Larsson TE, Baron R, Lanske B. Klotho expression in osteocytes regulates bone metabolism and controls bone formation. Kidney Int. 2017 09; 92(3):599-611. PMID: 28396120.
    View in: PubMed
  13. McClung M, Baron R, Bouxsein M. An update on osteoporosis pathogenesis, diagnosis, and treatment. Bone. 2017 05; 98:37. PMID: 28263916.
    View in: PubMed
  14. Xu Z, Greenblatt MB, Yan G, Feng H, Sun J, Lotinun S, Brady N, Baron R, Glimcher LH, Zou W. SMURF2 regulates bone homeostasis by disrupting SMAD3 interaction with vitamin D receptor in osteoblasts. Nat Commun. 2017 02 20; 8:14570. PMID: 28216630.
    View in: PubMed
  15. Kaludjerovic J, Komaba H, Sato T, Erben RG, Baron R, Olauson H, Larsson TE, Lanske B. Klotho expression in long bones regulates FGF23 production during renal failure. FASEB J. 2017 05; 31(5):2050-2064. PMID: 28183805.
    View in: PubMed
  16. Maridas DE, DeMambro VE, Le PT, Nagano K, Baron R, Mohan S, Rosen CJ. IGFBP-4 regulates adult skeletal growth in a sex-specific manner. J Endocrinol. 2017 04; 233(1):131-144. PMID: 28184001.
    View in: PubMed
  17. Fan Y, Hanai JI, Le PT, Bi R, Maridas D, DeMambro V, Figueroa CA, Kir S, Zhou X, Mannstadt M, Baron R, Bronson RT, Horowitz MC, Wu JY, Bilezikian JP, Dempster DW, Rosen CJ, Lanske B. Parathyroid Hormone Directs Bone Marrow Mesenchymal Cell Fate. Cell Metab. 2017 03 07; 25(3):661-672. PMID: 28162969.
    View in: PubMed
  18. Jin YR, Stohn JP, Wang Q, Nagano K, Baron R, Bouxsein ML, Rosen CJ, Adarichev VA, Lindner V. Inhibition of osteoclast differentiation and collagen antibody-induced arthritis by CTHRC1. Bone. 2017 04; 97:153-167. PMID: 28115279.
    View in: PubMed
  19. Sato K, Idelevich A, Nagano K, Rowe GC, Gori F, Baron R. Hypothalamic ?FosB prevents age-related metabolic decline and functions via SNS. Aging (Albany NY). 2017 01 20; 9(2):353-369. PMID: 28121620.
    View in: PubMed
  20. Gori F, Superti-Furga A, Baron R. Bone Formation and the Wnt Signaling Pathway. N Engl J Med. 2016 11 10; 375(19):1902-1903. PMID: 27959643.
    View in: PubMed
  21. Wein MN, Liang Y, Goransson O, Sundberg TB, Wang J, Williams EA, O'Meara MJ, Govea N, Beqo B, Nishimori S, Nagano K, Brooks DJ, Martins JS, Corbin B, Anselmo A, Sadreyev R, Wu JY, Sakamoto K, Foretz M, Xavier RJ, Baron R, Bouxsein ML, Gardella TJ, Divieti-Pajevic P, Gray NS, Kronenberg HM. SIKs control osteocyte responses to parathyroid hormone. Nat Commun. 2016 10 19; 7:13176. PMID: 27759007.
    View in: PubMed
  22. Kiper POS, Saito H, Gori F, Unger S, Hesse E, Yamana K, Kiviranta R, Solban N, Liu J, Brommage R, Boduroglu K, Bonafé L, Campos-Xavier B, Dikoglu E, Eastell R, Gossiel F, Harshman K, Nishimura G, Girisha KM, Stevenson BJ, Takita H, Rivolta C, Superti-Furga A, Baron R. Cortical-Bone Fragility--Insights from sFRP4 Deficiency in Pyle's Disease. N Engl J Med. 2016 Jun 30; 374(26):2553-2562. PMID: 27355534.
    View in: PubMed
  23. Zalli D, Neff L, Nagano K, Shin NY, Witke W, Gori F, Baron R. The Actin-Binding Protein Cofilin and Its Interaction With Cortactin Are Required for Podosome Patterning in Osteoclasts and Bone Resorption In Vivo and In Vitro. J Bone Miner Res. 2016 09; 31(9):1701-12. PMID: 27064822.
    View in: PubMed
  24. Greenblatt MB, Shin DY, Oh H, Lee KY, Zhai B, Gygi SP, Lotinun S, Baron R, Liu D, Su B, Glimcher LH, Shim JH. MEKK2 mediates an alternative ß-catenin pathway that promotes bone formation. Proc Natl Acad Sci U S A. 2016 Mar 01; 113(9):E1226-35. PMID: 26884171; PMCID: PMC4780654.
  25. DeMambro VE, Le PT, Guntur AR, Maridas DE, Canalis E, Nagano K, Baron R, Clemmons DR, Rosen CJ. Igfbp2 Deletion in Ovariectomized Mice Enhances Energy Expenditure but Accelerates Bone Loss. Endocrinology. 2015 Nov; 156(11):4129-40. PMID: 26230658; PMCID: PMC4606757 [Available on 11/01/16].
  26. Greenblatt MB, Park KH, Oh H, Kim JM, Shin DY, Lee JM, Lee JW, Singh A, Lee KY, Hu D, Xiao C, Charles JF, Penninger JM, Lotinun S, Baron R, Ghosh S, Shim JH. CHMP5 controls bone turnover rates by dampening NF-?B activity in osteoclasts. J Exp Med. 2015 Jul 27; 212(8):1283-301. PMID: 26195726; PMCID: PMC4516796.
  27. Shiwaku Y, Neff L, Nagano K, Takeyama K, de Bruijn J, Dard M, Gori F, Baron R. The Crosstalk between Osteoclasts and Osteoblasts Is Dependent upon the Composition and Structure of Biphasic Calcium Phosphates. PLoS One. 2015; 10(7):e0132903. PMID: 26193362; PMCID: PMC4507990.
  28. Gori F, Lerner U, Ohlsson C, Baron R. A new WNT on the bone: WNT16, cortical bone thickness, porosity and fractures. Bonekey Rep. 2015; 4:669. PMID: 25987984; PMCID: PMC4432781.
  29. Yu VW, Saez B, Cook C, Lotinun S, Pardo-Saganta A, Wang YH, Lymperi S, Ferraro F, Raaijmakers MH, Wu JY, Zhou L, Rajagopal J, Kronenberg HM, Baron R, Scadden DT. Specific bone cells produce DLL4 to generate thymus-seeding progenitors from bone marrow. J Exp Med. 2015 May 04; 212(5):759-74. PMID: 25918341; PMCID: PMC4419348.
  30. Zhang MZ, Ferrigno O, Wang Z, Ohnishi M, Prunier C, Levy L, Razzaque M, Horne WC, Romero D, Tzivion G, Colland F, Baron R, Atfi A. TGIF governs a feed-forward network that empowers Wnt signaling to drive mammary tumorigenesis. Cancer Cell. 2015 Apr 13; 27(4):547-60. PMID: 25873176; PMCID: PMC4398914.
  31. Motyl KJ, DeMambro VE, Barlow D, Olshan D, Nagano K, Baron R, Rosen CJ, Houseknecht KL. Propranolol Attenuates Risperidone-Induced Trabecular Bone Loss in Female Mice. Endocrinology. 2015 Jul; 156(7):2374-83. PMID: 25853667; PMCID: PMC4475716.
  32. Wein MN, Spatz J, Nishimori S, Doench J, Root D, Babij P, Nagano K, Baron R, Brooks D, Bouxsein M, Pajevic PD, Kronenberg HM. HDAC5 controls MEF2C-driven sclerostin expression in osteocytes. J Bone Miner Res. 2015 Mar; 30(3):400-11. PMID: 25271055; PMCID: PMC4342334.
  33. Lowery JW, Intini G, Gamer L, Lotinun S, Salazar VS, Ote S, Cox K, Baron R, Rosen V. Loss of BMPR2 leads to high bone mass due to increased osteoblast activity. J Cell Sci. 2015 Apr 01; 128(7):1308-15. PMID: 25663702; PMCID: PMC4379725.
  34. Movérare-Skrtic S, Henning P, Liu X, Nagano K, Saito H, Börjesson AE, Sjögren K, Windahl SH, Farman H, Kindlund B, Engdahl C, Koskela A, Zhang FP, Eriksson EE, Zaman F, Hammarstedt A, Isaksson H, Bally M, Kassem A, Lindholm C, Sandberg O, Aspenberg P, Sävendahl L, Feng JQ, Tuckermann J, Tuukkanen J, Poutanen M, Baron R, Lerner UH, Gori F, Ohlsson C. Osteoblast-derived WNT16 represses osteoclastogenesis and prevents cortical bone fragility fractures. Nat Med. 2014 Nov; 20(11):1279-88. PMID: 25306233; PMCID: PMC4392888.
  35. Shin NY, Choi H, Neff L, Wu Y, Saito H, Ferguson SM, De Camilli P, Baron R. Dynamin and endocytosis are required for the fusion of osteoclasts and myoblasts. J Cell Biol. 2014 Oct 13; 207(1):73-89. PMID: 25287300; PMCID: PMC4195819.
  36. Lai LP, Lotinun S, Bouxsein ML, Baron R, McMahon AP. Stk11 (Lkb1) deletion in the osteoblast lineage leads to high bone turnover, increased trabecular bone density and cortical porosity. Bone. 2014 Dec; 69:98-108. PMID: 25240456; PMCID: PMC4373701.
  37. Saez B, Ferraro F, Yusuf RZ, Cook CM, Yu VW, Pardo-Saganta A, Sykes SM, Palchaudhuri R, Schajnovitz A, Lotinun S, Lymperi S, Mendez-Ferrer S, Toro RD, Day R, Vasic R, Acharya SS, Baron R, Lin CP, Yamaguchi Y, Wagers AJ, Scadden DT. Inhibiting stromal cell heparan sulfate synthesis improves stem cell mobilization and enables engraftment without cytotoxic conditioning. Blood. 2014 Nov 06; 124(19):2937-47. PMID: 25202142; PMCID: PMC4224192.
  38. Swami A, Reagan MR, Basto P, Mishima Y, Kamaly N, Glavey S, Zhang S, Moschetta M, Seevaratnam D, Zhang Y, Liu J, Memarzadeh M, Wu J, Manier S, Shi J, Bertrand N, Lu ZN, Nagano K, Baron R, Sacco A, Roccaro AM, Farokhzad OC, Ghobrial IM. Engineered nanomedicine for myeloma and bone microenvironment targeting. Proc Natl Acad Sci U S A. 2014 Jul 15; 111(28):10287-92. PMID: 24982170; PMCID: PMC4104924.
  39. Bornstein S, Brown SA, Le PT, Wang X, DeMambro V, Horowitz MC, MacDougald O, Baron R, Lotinun S, Karsenty G, Wei W, Ferron M, Kovacs CS, Clemmons D, Wan Y, Rosen CJ. FGF-21 and skeletal remodeling during and after lactation in C57BL/6J mice. Endocrinology. 2014 Sep; 155(9):3516-26. PMID: 24914939; PMCID: PMC4138567.
  40. Addison WN, Fu MM, Yang HX, Lin Z, Nagano K, Gori F, Baron R. Direct transcriptional repression of Zfp423 by Zfp521 mediates a bone morphogenic protein-dependent osteoblast versus adipocyte lineage commitment switch. Mol Cell Biol. 2014 Aug; 34(16):3076-85. PMID: 24891617; PMCID: PMC4135594.
  41. Destaing O, Ferguson SM, Grichine A, Oddou C, De Camilli P, Albiges-Rizo C, Baron R. Essential function of dynamin in the invasive properties and actin architecture of v-Src induced podosomes/invadosomes. PLoS One. 2013; 8(12):e77956. PMID: 24348990; PMCID: PMC3857171.
  42. Biosse Duplan M, Zalli D, Stephens S, Zenger S, Neff L, Oelkers JM, Lai FP, Horne W, Rottner K, Baron R. Microtubule dynamic instability controls podosome patterning in osteoclasts through EB1, cortactin, and Src. Mol Cell Biol. 2014 Jan; 34(1):16-29. PMID: 24144981; PMCID: PMC3911273.
  43. Motyl KJ, Bishop KA, DeMambro VE, Bornstein SA, Le P, Kawai M, Lotinun S, Horowitz MC, Baron R, Bouxsein ML, Rosen CJ. Altered thermogenesis and impaired bone remodeling in Misty mice. J Bone Miner Res. 2013 Sep; 28(9):1885-97. PMID: 23553822; PMCID: PMC3743939.
  44. Nallamshetty S, Wang H, Rhee EJ, Kiefer FW, Brown JD, Lotinun S, Le P, Baron R, Rosen CJ, Plutzky J. Deficiency of retinaldehyde dehydrogenase 1 induces BMP2 and increases bone mass in vivo. PLoS One. 2013; 8(8):e71307. PMID: 23951127; PMCID: PMC3739807.
  45. Saini V, Marengi DA, Barry KJ, Fulzele KS, Heiden E, Liu X, Dedic C, Maeda A, Lotinun S, Baron R, Pajevic PD. Parathyroid hormone (PTH)/PTH-related peptide type 1 receptor (PPR) signaling in osteocytes regulates anabolic and catabolic skeletal responses to PTH. J Biol Chem. 2013 Jul 12; 288(28):20122-34. PMID: 23729679; PMCID: PMC3711281.
  46. Kiviranta R, Yamana K, Saito H, Ho DK, Laine J, Tarkkonen K, Nieminen-Pihala V, Hesse E, Correa D, Määttä J, Tessarollo L, Rosen ED, Horne WC, Jenkins NA, Copeland NG, Warming S, Baron R. Coordinated transcriptional regulation of bone homeostasis by Ebf1 and Zfp521 in both mesenchymal and hematopoietic lineages. J Exp Med. 2013 May 06; 210(5):969-85. PMID: 23569325; PMCID: PMC3646489.
  47. Retraction: The association between the microtubule plus end protein EB1 and cortactin controls podosomes and bone resorption. J Bone Miner Res. 2013 Apr; 28(4):970. PMID: 23620885.
    View in: PubMed
  48. Baron R, Kneissel M. WNT signaling in bone homeostasis and disease: from human mutations to treatments. Nat Med. 2013 Feb; 19(2):179-92. PMID: 23389618.
    View in: PubMed
  49. Simic P, Zainabadi K, Bell E, Sykes DB, Saez B, Lotinun S, Baron R, Scadden D, Schipani E, Guarente L. SIRT1 regulates differentiation of mesenchymal stem cells by deacetylating ß-catenin. EMBO Mol Med. 2013 Mar; 5(3):430-40. PMID: 23364955; PMCID: PMC3598082.
  50. Coury F, Zenger S, Stewart AK, Stephens S, Neff L, Tsang K, Shull GE, Alper SL, Baron R, Aliprantis AO. SLC4A2-mediated Cl-/HCO3- exchange activity is essential for calpain-dependent regulation of the actin cytoskeleton in osteoclasts. Proc Natl Acad Sci U S A. 2013 Feb 05; 110(6):2163-8. PMID: 23341620; PMCID: PMC3568349.
  51. Lotinun S, Kiviranta R, Matsubara T, Alzate JA, Neff L, Lüth A, Koskivirta I, Kleuser B, Vacher J, Vuorio E, Horne WC, Baron R. Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation. J Clin Invest. 2013 Feb; 123(2):666-81. PMID: 23321671; PMCID: PMC3561821.
  52. Idelevich A, Sato K, Baron R. What are the effects of leptin on bone and where are they exerted? J Bone Miner Res. 2013 Jan; 28(1):18-21. PMID: 23188700.
    View in: PubMed
  53. Kang S, Akerblad P, Kiviranta R, Gupta RK, Kajimura S, Griffin MJ, Min J, Baron R, Rosen ED. Regulation of early adipose commitment by Zfp521. PLoS Biol. 2012; 10(11):e1001433. PMID: 23209378; PMCID: PMC3507953.
  54. Fulzele K, Krause DS, Panaroni C, Saini V, Barry KJ, Liu X, Lotinun S, Baron R, Bonewald L, Feng JQ, Chen M, Weinstein LS, Wu JY, Kronenberg HM, Scadden DT, Divieti Pajevic P. Myelopoiesis is regulated by osteocytes through Gsa-dependent signaling. Blood. 2013 Feb 07; 121(6):930-9. PMID: 23160461; PMCID: PMC3567340.
  55. Liu Y, Berendsen AD, Jia S, Lotinun S, Baron R, Ferrara N, Olsen BR. Intracellular VEGF regulates the balance between osteoblast and adipocyte differentiation. J Clin Invest. 2012 Sep; 122(9):3101-13. PMID: 22886301; PMCID: PMC3428080.
  56. Rowe GC, Vialou V, Sato K, Saito H, Yin M, Green TA, Lotinun S, Kveiborg M, Horne WC, Nestler EJ, Baron R. Energy expenditure and bone formation share a common sensitivity to AP-1 transcription in the hypothalamus. J Bone Miner Res. 2012 Aug; 27(8):1649-58. PMID: 22461201; PMCID: PMC3399943.
  57. Lotinun S, Pearsall RS, Horne WC, Baron R. Activin receptor signaling: a potential therapeutic target for osteoporosis. Curr Mol Pharmacol. 2012 Jun; 5(2):195-204. PMID: 21787285.
    View in: PubMed
  58. Baron R, Saito H, Gori F. Bone cells crosstalk: noncanonical Roring in the Wnt. Cell Metab. 2012 Apr 04; 15(4):415-7. PMID: 22482722.
    View in: PubMed
  59. Baron R, Hesse E. Update on bone anabolics in osteoporosis treatment: rationale, current status, and perspectives. J Clin Endocrinol Metab. 2012 Feb; 97(2):311-25. PMID: 22238383; PMCID: PMC3275361.
  60. Baron R. Osteoporosis in 2011: Osteoporosis therapy--dawn of the post-bisphosphonate era. Nat Rev Endocrinol. 2011 Dec 06; 8(2):76-8. PMID: 22143180.
    View in: PubMed
  61. Zou W, Greenblatt MB, Shim JH, Kant S, Zhai B, Lotinun S, Brady N, Hu DZ, Gygi SP, Baron R, Davis RJ, Jones D, Glimcher LH. MLK3 regulates bone development downstream of the faciogenital dysplasia protein FGD1 in mice. J Clin Invest. 2011 Nov; 121(11):4383-92. PMID: 21965325; PMCID: PMC3204846.
  62. Motyl KJ, Dick-de-Paula I, Maloney AE, Lotinun S, Bornstein S, de Paula FJ, Baron R, Houseknecht KL, Rosen CJ. Trabecular bone loss after administration of the second-generation antipsychotic risperidone is independent of weight gain. Bone. 2012 Feb; 50(2):490-8. PMID: 21854880; PMCID: PMC3261344.
  63. Marzia M, Guaiquil V, Horne WC, Blobel CP, Baron R, Chiusaroli R. Lack of ADAM15 in mice is associated with increased osteoblast function and bone mass. Biol Chem. 2011 Oct; 392(10):877-85. PMID: 21801086.
    View in: PubMed
  64. de Paula FJ, Dick-de-Paula I, Bornstein S, Rostama B, Le P, Lotinun S, Baron R, Rosen CJ. VDR haploinsufficiency impacts body composition and skeletal acquisition in a gender-specific manner. Calcif Tissue Int. 2011 Sep; 89(3):179-91. PMID: 21637996; PMCID: PMC3157554.
  65. Seriwatanachai D, Densmore MJ, Sato T, Correa D, Neff L, Baron R, Lanske B. Deletion of Zfp521 rescues the growth plate phenotype in a mouse model of Jansen metaphyseal chondrodysplasia. FASEB J. 2011 Sep; 25(9):3057-67. PMID: 21642473; PMCID: PMC3157684.
  66. Moisan A, Rivera MN, Lotinun S, Akhavanfard S, Coffman EJ, Cook EB, Stoykova S, Mukherjee S, Schoonmaker JA, Burger A, Kim WJ, Kronenberg HM, Baron R, Haber DA, Bardeesy N. The WTX tumor suppressor regulates mesenchymal progenitor cell fate specification. Dev Cell. 2011 May 17; 20(5):583-596. PMID: 21571217; PMCID: PMC4052985.
  67. Christov M, Koren S, Yuan Q, Baron R, Lanske B. Genetic ablation of sfrp4 in mice does not affect serum phosphate homeostasis. Endocrinology. 2011 May; 152(5):2031-6. PMID: 21427221; PMCID: PMC3075942.
  68. Hesse E, Saito H, Kiviranta R, Correa D, Yamana K, Neff L, Toben D, Duda G, Atfi A, Geoffroy V, Horne WC, Baron R. Zfp521 controls bone mass by HDAC3-dependent attenuation of Runx2 activity. J Cell Biol. 2010 Dec 27; 191(7):1271-83. PMID: 21173110; PMCID: PMC3010073.
  69. Baron R, Ferrari S, Russell RG. Denosumab and bisphosphonates: different mechanisms of action and effects. Bone. 2011 Apr 01; 48(4):677-92. PMID: 21145999.
    View in: PubMed
  70. Correa D, Hesse E, Seriwatanachai D, Kiviranta R, Saito H, Yamana K, Neff L, Atfi A, Coillard L, Sitara D, Maeda Y, Warming S, Jenkins NA, Copeland NG, Horne WC, Lanske B, Baron R. Zfp521 is a target gene and key effector of parathyroid hormone-related peptide signaling in growth plate chondrocytes. Dev Cell. 2010 Oct 19; 19(4):533-46. PMID: 20951345; PMCID: PMC2958174.
  71. Devlin MJ, Cloutier AM, Thomas NA, Panus DA, Lotinun S, Pinz I, Baron R, Rosen CJ, Bouxsein ML. Caloric restriction leads to high marrow adiposity and low bone mass in growing mice. J Bone Miner Res. 2010 Sep; 25(9):2078-88. PMID: 20229598.
    View in: PubMed
  72. Greenblatt MB, Shim JH, Zou W, Sitara D, Schweitzer M, Hu D, Lotinun S, Sano Y, Baron R, Park JM, Arthur S, Xie M, Schneider MD, Zhai B, Gygi S, Davis R, Glimcher LH. The p38 MAPK pathway is essential for skeletogenesis and bone homeostasis in mice. J Clin Invest. 2010 Jul; 120(7):2457-73. PMID: 20551513; PMCID: PMC2898605.
  73. Schulze J, Seitz S, Saito H, Schneebauer M, Marshall RP, Baranowsky A, Busse B, Schilling AF, Friedrich FW, Albers J, Spiro AS, Zustin J, Streichert T, Ellwanger K, Niehrs C, Amling M, Baron R, Schinke T. Negative regulation of bone formation by the transmembrane Wnt antagonist Kremen-2. PLoS One. 2010 Apr 27; 5(4):e10309. PMID: 20436912; PMCID: PMC2860505.
  74. Atfi A, Baron R. PTH battles TGF-beta in bone. Nat Cell Biol. 2010 Mar; 12(3):205-7. PMID: 20190828.
    View in: PubMed
  75. Hesse E, Kiviranta R, Wu M, Saito H, Yamana K, Correa D, Atfi A, Baron R. Zinc finger protein 521, a new player in bone formation. Ann N Y Acad Sci. 2010 Mar; 1192:32-7. PMID: 20392215.
    View in: PubMed
  76. Guo J, Liu M, Yang D, Bouxsein ML, Saito H, Galvin RJ, Kuhstoss SA, Thomas CC, Schipani E, Baron R, Bringhurst FR, Kronenberg HM. Suppression of Wnt signaling by Dkk1 attenuates PTH-mediated stromal cell response and new bone formation. Cell Metab. 2010 Feb 03; 11(2):161-71. PMID: 20142103; PMCID: PMC2819982.
  77. Lotinun S, Pearsall RS, Davies MV, Marvell TH, Monnell TE, Ucran J, Fajardo RJ, Kumar R, Underwood KW, Seehra J, Bouxsein ML, Baron R. A soluble activin receptor Type IIA fusion protein (ACE-011) increases bone mass via a dual anabolic-antiresorptive effect in Cynomolgus monkeys. Bone. 2010 Apr; 46(4):1082-8. PMID: 20080223.
    View in: PubMed
  78. Purev E, Neff L, Horne WC, Baron R. c-Cbl and Cbl-b act redundantly to protect osteoclasts from apoptosis and to displace HDAC6 from beta-tubulin, stabilizing microtubules and podosomes. Mol Biol Cell. 2009 Sep; 20(18):4021-30. PMID: 19641021.
    View in: PubMed
  79. Nakajima A, Sanjay A, Chiusaroli R, Adapala NS, Neff L, Itzsteink C, Horne WC, Baron R. Loss of Cbl-b increases osteoclast bone-resorbing activity and induces osteopenia. J Bone Miner Res. 2009 Jul; 24(7):1162-72. PMID: 19257814; PMCID: PMC2697622.
  80. Bruzzaniti A, Neff L, Sandoval A, Du L, Horne WC, Baron R. Dynamin reduces Pyk2 Y402 phosphorylation and SRC binding in osteoclasts. Mol Cell Biol. 2009 Jul; 29(13):3644-56. PMID: 19380485; PMCID: PMC2698752.
  81. Alles N, Soysa NS, Hussain MD, Tomomatsu N, Saito H, Baron R, Morimoto N, Aoki K, Akiyoshi K, Ohya K. Polysaccharide nanogel delivery of a TNF-alpha and RANKL antagonist peptide allows systemic prevention of bone loss. Eur J Pharm Sci. 2009 May 12; 37(2):83-8. PMID: 19429414.
    View in: PubMed
  82. Wu M, Hesse E, Morvan F, Zhang JP, Correa D, Rowe GC, Kiviranta R, Neff L, Philbrick WM, Horne WC, Baron R. Zfp521 antagonizes Runx2, delays osteoblast differentiation in vitro, and promotes bone formation in vivo. Bone. 2009 Apr; 44(4):528-36. PMID: 19095088; PMCID: PMC2746087.
  83. Rowe GC, Choi CS, Neff L, Horne WC, Shulman GI, Baron R. Increased energy expenditure and insulin sensitivity in the high bone mass DeltaFosB transgenic mice. Endocrinology. 2009 Jan; 150(1):135-43. PMID: 18772235; PMCID: PMC2630902.
  84. Atfi A, Baron R. p53 brings a new twist to the Smad signaling network. Sci Signal. 2008 Jul 01; 1(26):pe33. PMID: 18594115.
    View in: PubMed
  85. Ellwanger K, Saito H, Clément-Lacroix P, Maltry N, Niedermeyer J, Lee WK, Baron R, Rawadi G, Westphal H, Niehrs C. Targeted disruption of the Wnt regulator Kremen induces limb defects and high bone density. Mol Cell Biol. 2008 Aug; 28(15):4875-82. PMID: 18505822; PMCID: PMC2493355.
  86. Sabatakos G, Rowe GC, Kveiborg M, Wu M, Neff L, Chiusaroli R, Philbrick WM, Baron R. Doubly truncated FosB isoform (Delta2DeltaFosB) induces osteosclerosis in transgenic mice and modulates expression and phosphorylation of Smads in osteoblasts independent of intrinsic AP-1 activity. J Bone Miner Res. 2008 May; 23(5):584-95. PMID: 18433296; PMCID: PMC2674536.
  87. Sabatakos G. Rowe GC, Kveiborg M, Wu M, Neff L, Chiusaroli R, Philbrick WM, Baron R. The doubly truncated FosB isoform (Delta2DeltaFosB) induces osteosclerosis in transgenic mice and modulates expression and phosphorylation of Smads in osteoblasts independent of intrinsic AP-1 activity. J Bone and Min. Res. 2008; 23:584-595.
  88. Wang L, Tassiulas I, Park-Min KH, Reid AC, Gil-Henn H, Schlessinger J, Baron R, Zhang JJ, Ivashkiv LB. 'Tuning' of type I interferon-induced Jak-STAT1 signaling by calcium-dependent kinases in macrophages. Nat Immunol. 2008 Feb; 9(2):186-93. PMID: 18084294.
    View in: PubMed
  89. Destaing O, Sanjay A, Itzstein C, Horne WC, Toomre D, De Camilli P, Baron R. The tyrosine kinase activity of c-Src regulates actin dynamics and organization of podosomes in osteoclasts. Mol Biol Cell. 2008 Jan; 19(1):394-404. PMID: 17978100.
    View in: PubMed
  90. Li L, Hisamoto K, Kim KH, Haynes MP, Bauer PM, Sanjay A, Collinge M, Baron R, Sessa WC, Bender JR. Variant estrogen receptor-c-Src molecular interdependence and c-Src structural requirements for endothelial NO synthase activation. Proc Natl Acad Sci U S A. 2007 Oct 16; 104(42):16468-73. PMID: 17921256; PMCID: PMC2034248.
  91. Garcia T, Jackson A, Bachelier R, Clément-Lacroix P, Baron R, Clézardin P, Pujuguet P. A convenient clinically relevant model of human breast cancer bone metastasis. Clin Exp Metastasis. 2008; 25(1):33-42. PMID: 17902030.
    View in: PubMed
  92. Gil-Henn H, Destaing O, Sims NA, Aoki K, Alles N, Neff L, Sanjay A, Bruzzaniti A, De Camilli P, Baron R, Schlessinger J. Defective microtubule-dependent podosome organization in osteoclasts leads to increased bone density in Pyk2(-/-) mice. J Cell Biol. 2007 Sep 10; 178(6):1053-64. PMID: 17846174; PMCID: PMC2064627.
  93. Zhao Y, Bachelier R, Treilleux I, Pujuguet P, Peyruchaud O, Baron R, Clément-Lacroix P, Clézardin P. Tumor alphavbeta3 integrin is a therapeutic target for breast cancer bone metastases. Cancer Res. 2007 Jun 15; 67(12):5821-30. PMID: 17575150.
    View in: PubMed
  94. Baron R, Rawadi G. Wnt signaling and the regulation of bone mass. Curr Osteoporos Rep. 2007 Jun; 5(2):73-80. PMID: 17521509.
    View in: PubMed
  95. Bonaventure J, Gibbs L, Horne WC, Baron R. The localization of FGFR3 mutations causing thanatophoric dysplasia type I differentially affects phosphorylation, processing and ubiquitylation of the receptor. FEBS J. 2007 Jun; 274(12):3078-93. PMID: 17509076.
    View in: PubMed
  96. Saito H, Kojima T, Takahashi M, Horne WC, Baron R, Amagasa T, Ohya K, Aoki K. A tumor necrosis factor receptor loop peptide mimic inhibits bone destruction to the same extent as anti-tumor necrosis factor monoclonal antibody in murine collagen-induced arthritis. Arthritis Rheum. 2007 Apr; 56(4):1164-74. PMID: 17393436.
    View in: PubMed
  97. Baron R, Rawadi G. Targeting the Wnt/beta-catenin pathway to regulate bone formation in the adult skeleton. Endocrinology. 2007 Jun; 148(6):2635-43. PMID: 17395698.
    View in: PubMed
  98. Lin HS, Hu CY, Chan HY, Liew YY, Huang HP, Lepescheux L, Bastianelli E, Baron R, Rawadi G, Clément-Lacroix P. Anti-rheumatic activities of histone deacetylase (HDAC) inhibitors in vivo in collagen-induced arthritis in rodents. Br J Pharmacol. 2007 Apr; 150(7):862-72. PMID: 17325656; PMCID: PMC2013883.
  99. Wang L, Tassiulas I, Gil-Henn H, Schlessinger J, Baron R, Zhang J, Ivashkiv LB. Regulation of Macrophage Jak activation and STAT1 tyrosine phosphorylation by ITAM-associated receptors in mediated by calcium-dependent CaMK and Pyk2. Nature Immunology. 2007; 9:186-193.
  100. Sanjay A, Miyazaki T, Itzstein C, Purev E, Horne WC, Baron R. Identification and functional characterization of an Src homology domain 3 domain-binding site on Cbl. FEBS J. 2006 Dec; 273(23):5442-56. PMID: 17094785.
    View in: PubMed
  101. Windahl SH, Galien R, Chiusaroli R, Clément-Lacroix P, Morvan F, Lepescheux L, Nique F, Horne WC, Resche-Rigon M, Baron R. Bone protection by estrens occurs through non-tissue-selective activation of the androgen receptor. J Clin Invest. 2006 Sep; 116(9):2500-9. PMID: 16955145; PMCID: PMC1555662.
  102. Koga F, Xu W, Karpova TS, McNally JG, Baron R, Neckers L. Hsp90 inhibition transiently activates Src kinase and promotes Src-dependent Akt and Erk activation. Proc Natl Acad Sci U S A. 2006 Jul 25; 103(30):11318-22. PMID: 16844778; PMCID: PMC1544084.
  103. Morvan F, Boulukos K, Clément-Lacroix P, Roman Roman S, Suc-Royer I, Vayssière B, Ammann P, Martin P, Pinho S, Pognonec P, Mollat P, Niehrs C, Baron R, Rawadi G. Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass. J Bone Miner Res. 2006 Jun; 21(6):934-45. PMID: 16753024.
    View in: PubMed
  104. Bruzzaniti A, Baron R. Molecular regulation of osteoclast activity. Rev Endocr Metab Disord. 2006 Jun; 7(1-2):123-39. PMID: 16951988.
    View in: PubMed
  105. Aoki K, Saito H, Itzstein C, Ishiguro M, Shibata T, Blanque R, Mian AH, Takahashi M, Suzuki Y, Yoshimatsu M, Yamaguchi A, Deprez P, Mollat P, Murali R, Ohya K, Horne WC, Baron R. A TNF receptor loop peptide mimic blocks RANK ligand-induced signaling, bone resorption, and bone loss. J Clin Invest. 2006 Jun; 116(6):1525-34. PMID: 16680194; PMCID: PMC1448165.
  106. Baron R. FSH versus estrogen: who's guilty of breaking bones? Cell Metab. 2006 May; 3(5):302-5. PMID: 16679287.
    View in: PubMed
  107. Suzuki Y, Aoki K, Saito H, Umeda M, Nitta H, Baron R, Ohya K. A tumor necrosis factor-alpha antagonist inhibits inflammatory bone resorption induced by Porphyromonas gingivalis infection in mice. J Periodontal Res. 2006 Apr; 41(2):81-91. PMID: 16499710.
    View in: PubMed
  108. Marzia M, Chiusaroli R, Neff L, Kim NY, Chishti AH, Baron R, Horne WC. Calpain is required for normal osteoclast function and is down-regulated by calcitonin. J Biol Chem. 2006 Apr 07; 281(14):9745-54. PMID: 16461769; PMCID: PMC1570620.
  109. Koga F, Xu W, Karpova TS, McNally JG, Baron R, Neckers L. Hsp90 inhibition transiently activates Src kinase and promotes Src-dependent Akt and Erk activation. Proc. Nat. Acad. Sci. USA. 2006; 103:11318-11322.
  110. Baron R, Rawadi G, Roman-Roman S. Wnt signaling: a key regulator of bone mass. Curr Top Dev Biol. 2006; 76:103-27. PMID: 17118265.
    View in: PubMed
  111. Miyazaki T, Tanaka S, Sanjay A, Baron R. The role of c-Src kinase in the regulation of osteoclast function. Mod Rheumatol. 2006; 16(2):68-74. PMID: 16633924.
    View in: PubMed
  112. Horne WC, Sanjay A, Bruzzaniti A, Baron R. The role(s) of Src kinase and Cbl proteins in the regulation of osteoclast differentiation and function. Immunol Rev. 2005 Dec; 208:106-25. PMID: 16313344.
    View in: PubMed
  113. Clément-Lacroix P, Ai M, Morvan F, Roman-Roman S, Vayssière B, Belleville C, Estrera K, Warman ML, Baron R, Rawadi G. Lrp5-independent activation of Wnt signaling by lithium chloride increases bone formation and bone mass in mice. Proc Natl Acad Sci U S A. 2005 Nov 29; 102(48):17406-11. PMID: 16293698; PMCID: PMC1297659.
  114. Rucci N, DiGiacinto C, Orrù L, Millimaggi D, Baron R, Teti A. A novel protein kinase C alpha-dependent signal to ERK1/2 activated by alphaVbeta3 integrin in osteoclasts and in Chinese hamster ovary (CHO) cells. J Cell Sci. 2005 Aug 01; 118(Pt 15):3263-75. PMID: 16014375.
    View in: PubMed
  115. Bruzzaniti A, Neff L, Sanjay A, Horne WC, De Camilli P, Baron R. Dynamin forms a Src kinase-sensitive complex with Cbl and regulates podosomes and osteoclast activity. Mol Biol Cell. 2005 Jul; 16(7):3301-13. PMID: 15872089.
    View in: PubMed
  116. Seck T, Pellegrini M, Florea AM, Grignoux V, Baron R, Mierke DF, Horne WC. The delta e13 isoform of the calcitonin receptor forms a six-transmembrane domain receptor with dominant-negative effects on receptor surface expression and signaling. Mol Endocrinol. 2005 Aug; 19(8):2132-44. PMID: 15860547; PMCID: PMC1242195.
  117. Jackson A, Vayssière B, Garcia T, Newell W, Baron R, Roman-Roman S, Rawadi G. Gene array analysis of Wnt-regulated genes in C3H10T1/2 cells. Bone. 2005 Apr; 36(4):585-98. PMID: 15777744.
    View in: PubMed
  118. Kojima T, Aoki K, Nonaka K, Saito H, Azuma M, Iwai H, Varghese BJ, Yoshimasu H, Baron R, Ohya K, Amagasa T. Subcutaneous injections of a TNF-alpha antagonistic peptide inhibit both inflammation and bone resorption in collagen-induced murine arthritis. J Med Dent Sci. 2005 Mar; 52(1):91-9. PMID: 15868746.
    View in: PubMed
  119. Hay E, Faucheu C, Suc-Royer I, Touitou R, Stiot V, Vayssière B, Baron R, Roman-Roman S, Rawadi G. Interaction between LRP5 and Frat1 mediates the activation of the Wnt canonical pathway. J Biol Chem. 2005 Apr 08; 280(14):13616-23. PMID: 15699046.
    View in: PubMed
  120. Baron R, Horne WC. Regulation of osteoclast activity. Bone Resorption, F Bronner, MC Farach-Carson, J Rubin, Eds. 2005; 34-57.
  121. Ammann P, Bourrin S, Brunner F, Meyer JM, Clément-Lacroix P, Baron R, Gaillard M, Rizzoli R. A new selective estrogen receptor modulator HMR-3339 fully corrects bone alterations induced by ovariectomy in adult rats. Bone. 2004 Jul; 35(1):153-61. PMID: 15207751.
    View in: PubMed
  122. Baron R. Arming the osteoclast. Nat Med. 2004 May; 10(5):458-60. PMID: 15122243.
    View in: PubMed
  123. Kveiborg M, Sabatakos G, Chiusaroli R, Wu M, Philbrick WM, Horne WC, Baron R. DeltaFosB induces osteosclerosis and decreases adipogenesis by two independent cell-autonomous mechanisms. Mol Cell Biol. 2004 Apr; 24(7):2820-30. PMID: 15024071; PMCID: PMC371096.
  124. Miyazaki T, Sanjay A, Neff L, Tanaka S, Horne WC, Baron R. Src kinase activity is essential for osteoclast function. J Biol Chem. 2004 Apr 23; 279(17):17660-6. PMID: 14739300.
    View in: PubMed
  125. Zhou HM, Weskamp G, Chesneau V, Sahin U, Vortkamp A, Horiuchi K, Chiusaroli R, Hahn R, Wilkes D, Fisher P, Baron R, Manova K, Basson CT, Hempstead B, Blobel CP. Essential role for ADAM19 in cardiovascular morphogenesis. Mol Cell Biol. 2004 Jan; 24(1):96-104. PMID: 14673146; PMCID: PMC303363.
  126. Baron R, Horne WC. The regulation of osteoclast activation. Topics in Bone Biology: Bone Resorption, Rubin J, Farach-Carson M, Bronner F, Eds. 2004.
  127. Longo M, Brama M, Marino M, Bernardini S, Korach KS, Wetsel WC, Scandurra R, Faraggiana T, Spera G, Baron R, Teti A, Migliaccio S. Interaction of estrogen receptor alpha with protein kinase C alpha and c-Src in osteoblasts during differentiation. Bone. 2004 Jan; 34(1):100-11. PMID: 14751567.
    View in: PubMed
  128. Akiyama T, Bouillet P, Miyazaki T, Kadono Y, Chikuda H, Chung UI, Fukuda A, Hikita A, Seto H, Okada T, Inaba T, Sanjay A, Baron R, Kawaguchi H, Oda H, Nakamura K, Strasser A, Tanaka S. Regulation of osteoclast apoptosis by ubiquitylation of proapoptotic BH3-only Bcl-2 family member Bim. EMBO J. 2003 Dec 15; 22(24):6653-64. PMID: 14657036; PMCID: PMC291830.
  129. Roman-Roman S, Shi DL, Stiot V, Haÿ E, Vayssière B, Garcia T, Baron R, Rawadi G. Murine Frizzled-1 behaves as an antagonist of the canonical Wnt/beta-catenin signaling. J Biol Chem. 2004 Feb 13; 279(7):5725-33. PMID: 14627707.
    View in: PubMed
  130. Shin HI, Divieti P, Sims NA, Kobayashi T, Miao D, Karaplis AC, Baron R, Bringhurst R, Kronenberg HM. Gp130-mediated signaling is necessary for normal osteoblastic function in vivo and in vitro. Endocrinology. 2004 Mar; 145(3):1376-85. PMID: 14617570.
    View in: PubMed
  131. Chiusaroli R, Knobler H, Luxenburg C, Sanjay A, Granot-Attas S, Tiran Z, Miyazaki T, Harmelin A, Baron R, Elson A. Tyrosine phosphatase epsilon is a positive regulator of osteoclast function in vitro and in vivo. Mol Biol Cell. 2004 Jan; 15(1):234-44. PMID: 14528021.
    View in: PubMed
  132. Rawadi G, Vayssière B, Dunn F, Baron R, Roman-Roman S. BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop. J Bone Miner Res. 2003 Oct; 18(10):1842-53. PMID: 14584895.
    View in: PubMed
  133. Chiusaroli R, Sanjay A, Henriksen K, Engsig MT, Horne WC, Gu H, Baron R. Deletion of the gene encoding c-Cbl alters the ability of osteoclasts to migrate, delaying resorption and ossification of cartilage during the development of long bones. Dev Biol. 2003 Sep 15; 261(2):537-47. PMID: 14499658.
    View in: PubMed
  134. Chiusaroli R, Maier A, Knight MC, Byrne M, Calvi LM, Baron R, Krane SM, Schipani E. Collagenase cleavage of type I collagen is essential for both basal and parathyroid hormone (PTH)/PTH-related peptide receptor-induced osteoclast activation and has differential effects on discrete bone compartments. Endocrinology. 2003 Sep; 144(9):4106-16. PMID: 12933685.
    View in: PubMed
  135. Horiuchi K, Weskamp G, Lum L, Hammes HP, Cai H, Brodie TA, Ludwig T, Chiusaroli R, Baron R, Preissner KT, Manova K, Blobel CP. Potential role for ADAM15 in pathological neovascularization in mice. Mol Cell Biol. 2003 Aug; 23(16):5614-24. PMID: 12897135; PMCID: PMC166329.
  136. Sims NA, Clément-Lacroix P, Minet D, Fraslon-Vanhulle C, Gaillard-Kelly M, Resche-Rigon M, Baron R. A functional androgen receptor is not sufficient to allow estradiol to protect bone after gonadectomy in estradiol receptor-deficient mice. J Clin Invest. 2003 May; 111(9):1319-27. PMID: 12727923; PMCID: PMC154447.
  137. Roman-Roman S, Garcia T, Jackson A, Theilhaber J, Rawadi G, Connolly T, Spinella-Jaegle S, Kawai S, Courtois B, Bushnell S, Auberval M, Call K, Baron R. Identification of genes regulated during osteoblastic differentiation by genome-wide expression analysis of mouse calvaria primary osteoblasts in vitro. Bone. 2003 May; 32(5):474-82. PMID: 12753863.
    View in: PubMed
  138. Seck T, Baron R, Horne WC. The alternatively spliced deltae13 transcript of the rabbit calcitonin receptor dimerizes with the C1a isoform and inhibits its surface expression. J Biol Chem. 2003 Jun 20; 278(25):23085-93. PMID: 12686555.
    View in: PubMed
  139. Miyazaki T, Neff L, Tanaka S, Horne WC, Baron R. Regulation of cytochrome c oxidase activity by c-Src in osteoclasts. J Cell Biol. 2003 Mar 03; 160(5):709-18. PMID: 12615910; PMCID: PMC2173369.
  140. Seck T, Baron R, Horne WC. Binding of filamin to the C-terminal tail of the calcitonin receptor controls recycling. J Biol Chem. 2003 Mar 21; 278(12):10408-16. PMID: 12531889.
    View in: PubMed
  141. Baron R. General principals of bone biology. Primer on the metabolic bone diseases and disorders of mineral metabolism, Favus M, Ed. 2003; 1-8.
  142. Haynes MP, Li L, Sinha D, Russell KS, Hisamoto K, Baron R, Collinge M, Sessa WC, Bender JR. Src kinase mediates phosphatidylinositol 3-kinase/Akt-dependent rapid endothelial nitric-oxide synthase activation by estrogen. J Biol Chem. 2003 Jan 24; 278(4):2118-23. PMID: 12431978.
    View in: PubMed
  143. Kveiborg M, Chiusaroli R, Sims NA, Wu M, Sabatakos G, Horne WC, Baron R. The increased bone mass in deltaFosB transgenic mice is independent of circulating leptin levels. Endocrinology. 2002 Nov; 143(11):4304-9. PMID: 12399426.
    View in: PubMed
  144. Mandine E, Jean-Baptiste V, Vayssière B, Gofflo D, Bénard D, Sarubbi E, Deprez P, Baron R, Superti-Furga G, Lesuisse D. High-affinity Src-SH2 ligands which do not activate Tyr(527)-phosphorylated Src in an experimental in vivo system. Biochem Biophys Res Commun. 2002 Oct 25; 298(2):185-92. PMID: 12387813.
    View in: PubMed
  145. Zhang Z, Neff L, Bothwell AL, Baron R, Horne WC. Calcitonin induces dephosphorylation of Pyk2 and phosphorylation of focal adhesion kinase in osteoclasts. Bone. 2002 Sep; 31(3):359-65. PMID: 12231407.
    View in: PubMed
  146. Baron R, Tsouderos Y. In vitro effects of S12911-2 on osteoclast function and bone marrow macrophage differentiation. Eur J Pharmacol. 2002 Aug 16; 450(1):11-7. PMID: 12176103.
    View in: PubMed
  147. Teti A, Migliaccio S, Baron R. The role of the alphaVbeta3 integrin in the development of osteolytic bone metastases: a pharmacological target for alternative therapy? Calcif Tissue Int. 2002 Oct; 71(4):293-9. PMID: 12154391.
    View in: PubMed
  148. Garcia T, Roman-Roman S, Jackson A, Theilhaber J, Connolly T, Spinella-Jaegle S, Kawai S, Courtois B, Bushnell S, Auberval M, Call K, Baron R. Behavior of osteoblast, adipocyte, and myoblast markers in genome-wide expression analysis of mouse calvaria primary osteoblasts in vitro. Bone. 2002 Jul; 31(1):205-11. PMID: 12110436.
    View in: PubMed
  149. Sims NA, Baron R. Bone: Structure, function, growth and remodeling. Orthopaedics, Firzgerald R, Kaufer H, Malkani AL, Eds. 2002; Section 2, Chapter 2:147-159.
  150. Duong LT, Sanjay A, Horne WC, Baron R, Rodan G. Integrin and calcitonin receptor signaling in the regulation of the cytoskeleton and function of the osteoclast. Principles of Bone Biology, Bilezikian J, Raisz L, Rodan G, Eds. 2002; Chapter 9:141-150.
  151. Bard F, Patel U, Levy JB, Jurdic P, Horne WC, Baron R. Molecular complexes that contain both c-Cbl and c-Src associate with Golgi membranes. Eur J Cell Biol. 2002 Jan; 81(1):26-35. PMID: 11893076.
    View in: PubMed
  152. Sims NA, Dupont S, Krust A, Clement-Lacroix P, Minet D, Resche-Rigon M, Gaillard-Kelly M, Baron R. Deletion of estrogen receptors reveals a regulatory role for estrogen receptors-beta in bone remodeling in females but not in males. Bone. 2002 Jan; 30(1):18-25. PMID: 11792560.
    View in: PubMed
  153. Theilhaber J, Connolly T, Roman-Roman S, Bushnell S, Jackson A, Call K, Garcia T, Baron R. Finding genes in the C2C12 osteogenic pathway by k-nearest-neighbor classification of expression data. Genome Res. 2002 Jan; 12(1):165-76. PMID: 11779842; PMCID: PMC155256.
  154. Sims NA, Sabatakos G, Chen JS, Kelz MB, Nestler EJ, Baron R. Regulating DeltaFosB expression in adult Tet-Off-DeltaFosB transgenic mice alters bone formation and bone mass. Bone. 2002 Jan; 30(1):32-9. PMID: 11792562.
    View in: PubMed
  155. Baron R, Sanjay A. The role of Src, Cbl and Pyk2 in vitronectin receptor-mediated adhesion in osteoclasts. Molecular Biology in Orthopaedics, Rosier RN, Evans CE, Eds. 2002; 221-228.
  156. Sanjay A, Horne WC, Baron R. The Cbl family: ubiquitin ligases regulating signaling by tyrosine kinases. Sci STKE. 2001 Nov 27; 2001(110):pe40. PMID: 11724969.
    View in: PubMed
  157. Gong Y, Slee RB, Fukai N, Rawadi G, Roman-Roman S, Reginato AM, Wang H, Cundy T, Glorieux FH, Lev D, Zacharin M, Oexle K, Marcelino J, Suwairi W, Heeger S, Sabatakos G, Apte S, Adkins WN, Allgrove J, Arslan-Kirchner M, Batch JA, Beighton P, Black GC, Boles RG, Boon LM, Borrone C, Brunner HG, Carle GF, Dallapiccola B, De Paepe A, Floege B, Halfhide ML, Hall B, Hennekam RC, Hirose T, Jans A, Jüppner H, Kim CA, Keppler-Noreuil K, Kohlschuetter A, LaCombe D, Lambert M, Lemyre E, Letteboer T, Peltonen L, Ramesar RS, Romanengo M, Somer H, Steichen-Gersdorf E, Steinmann B, Sullivan B, Superti-Furga A, Swoboda W, van den Boogaard MJ, Van Hul W, Vikkula M, Votruba M, Zabel B, Garcia T, Baron R, Olsen BR, Warman ML. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell. 2001 Nov 16; 107(4):513-23. PMID: 11719191.
    View in: PubMed
  158. Rawadi G, Ferrer C, Spinella-Jaegle S, Roman-Roman S, Bouali Y, Baron R. 1-(5-oxohexyl)-3,7-Dimethylxanthine, a phosphodiesterase inhibitor, activates MAPK cascades and promotes osteoblast differentiation by a mechanism independent of PKA activation (pentoxifylline promotes osteoblast differentiation). Endocrinology. 2001 Nov; 142(11):4673-82. PMID: 11606432.
    View in: PubMed
  159. Spinella-Jaegle S, Roman-Roman S, Faucheu C, Dunn FW, Kawai S, Galléa S, Stiot V, Blanchet AM, Courtois B, Baron R, Rawadi G. Opposite effects of bone morphogenetic protein-2 and transforming growth factor-beta1 on osteoblast differentiation. Bone. 2001 Oct; 29(4):323-30. PMID: 11595614.
    View in: PubMed
  160. Santhanagopal A, Chidiac P, Horne WC, Baron R, Dixon SJ. Calcitonin (CT) rapidly increases NA(+)/H(+) exchange and metabolic acid production: effects mediated selectively by the C1A CT receptor isoform. Endocrinology. 2001 Oct; 142(10):4401-13. PMID: 11564704.
    View in: PubMed
  161. Peña CS, Saini S, Baron RL, Hamm BA, Morana G, Caudana R, Giovagnoni A, Villa A, Carriero A, Mathieu D, Bourne MW, Kirchin MA, Pirovano G, Spinazzi A. Detection of malignant primary hepatic neoplasms with gadobenate dimeglumine (Gd-BOPTA) enhanced T1-weighted hepatocyte phase MR imaging: results of off-site blinded review in a phase-II multicenter trial. Korean J Radiol. 2001 Oct-Dec; 2(4):210-5. PMID: 11754328; PMCID: PMC2718123.
  162. Santhanagopal A, Chidiac P, Horne WC, Baron R, Dixon SJ. Calcitonin (CT) Rapidly Increases Na+/H+ Exchange and Metabolic Acid Production: Effects Mediated Selectively by the C1a CT Receptor Isoform. Endocrinology. 2001 Oct 01; 142(10):4401-4413. PMID: 28201301.
    View in: PubMed
  163. Wakioka T, Sasaki A, Kato R, Shouda T, Matsumoto A, Miyoshi K, Tsuneoka M, Komiya S, Baron R, Yoshimura A. Spred is a Sprouty-related suppressor of Ras signalling. Nature. 2001 Aug 09; 412(6847):647-51. PMID: 11493923.
    View in: PubMed
  164. Peyman A, Scheunemann K, Will DW, Knolle J, Wehner V, Breipohl G, Stilz HU, Carniato D, Ruxer J, Gourvest J, Auberval M, Doucet B, Baron R, Gaillard M, Gadek TR, Bodary S. alpha(v)beta(3) Antagonists based on a central thiophene scaffold. Bioorg Med Chem Lett. 2001 Aug 06; 11(15):2011-5. PMID: 11454469.
    View in: PubMed
  165. Yokouchi M, Kondo T, Sanjay A, Houghton A, Yoshimura A, Komiya S, Zhang H, Baron R. Src-catalyzed phosphorylation of c-Cbl leads to the interdependent ubiquitination of both proteins. J Biol Chem. 2001 Sep 14; 276(37):35185-93. PMID: 11448952.
    View in: PubMed
  166. David JP, Rincon M, Neff L, Horne WC, Baron R. Carbonic anhydrase II is an AP-1 target gene in osteoclasts. J Cell Physiol. 2001 Jul; 188(1):89-97. PMID: 11382925.
    View in: PubMed
  167. Spinella-Jaegle S, Rawadi G, Kawai S, Gallea S, Faucheu C, Mollat P, Courtois B, Bergaud B, Ramez V, Blanchet AM, Adelmant G, Baron R, Roman-Roman S. Sonic hedgehog increases the commitment of pluripotent mesenchymal cells into the osteoblastic lineage and abolishes adipocytic differentiation. J Cell Sci. 2001 Jun; 114(Pt 11):2085-94. PMID: 11493644.
    View in: PubMed
  168. Gallea S, Lallemand F, Atfi A, Rawadi G, Ramez V, Spinella-Jaegle S, Kawai S, Faucheu C, Huet L, Baron R, Roman-Roman S. Activation of mitogen-activated protein kinase cascades is involved in regulation of bone morphogenetic protein-2-induced osteoblast differentiation in pluripotent C2C12 cells. Bone. 2001 May; 28(5):491-8. PMID: 11344048.
    View in: PubMed
  169. Rajapurohitam V, Chalhoub N, Benachenhou N, Neff L, Baron R, Vacher J. The mouse osteopetrotic grey-lethal mutation induces a defect in osteoclast maturation/function. Bone. 2001 May; 28(5):513-23. PMID: 11344051.
    View in: PubMed
  170. Perez M, Migliaccio S, Taranta A, Festuccia C, Orrù L, Brama M, Bologna M, Faraggiana T, Baron R, Teti A. Melanoma cells stimulate osteoclastogenesis, c-Src expression and osteoblast cytokines. Eur J Cancer. 2001 Mar; 37(5):629-40. PMID: 11290439.
    View in: PubMed
  171. Calvi LM, Sims NA, Hunzelman JL, Knight MC, Giovannetti A, Saxton JM, Kronenberg HM, Baron R, Schipani E. Activated parathyroid hormone/parathyroid hormone-related protein receptor in osteoblastic cells differentially affects cortical and trabecular bone. J Clin Invest. 2001 Feb; 107(3):277-86. PMID: 11160151; PMCID: PMC199196.
  172. Sanjay A, Houghton A, Neff L, DiDomenico E, Bardelay C, Antoine E, Levy J, Gailit J, Bowtell D, Horne WC, Baron R. Cbl associates with Pyk2 and Src to regulate Src kinase activity, alpha(v)beta(3) integrin-mediated signaling, cell adhesion, and osteoclast motility. J Cell Biol. 2001 Jan 08; 152(1):181-95. PMID: 11149930; PMCID: PMC2193648.
  173. Violette SM, Guan W, Bartlett C, Smith JA, Bardelay C, Antoine E, Rickles RJ, Mandine E, van Schravendijk MR, Adams SE, Lynch BA, Shakespeare WC, Yang M, Jacobsen VA, Takeuchi CS, Macek KJ, Bohacek RS, Dalgarno DC, Weigele M, Lesuisse D, Sawyer TK, Baron R. Bone-targeted Src SH2 inhibitors block Src cellular activity and osteoclast-mediated resorption. Bone. 2001 Jan; 28(1):54-64. PMID: 11165943.
    View in: PubMed
  174. Baron R. L'osteoclaste et les mecanismes moleculaires de la resorption osseuse. (Invited Review). Medecine et Sciences. 2001; 17:1260-1269.
  175. Zhang Z, Baron R, Horne WC. Integrin engagement, the actin cytoskeleton, and c-Src are required for the calcitonin-induced tyrosine phosphorylation of paxillin and HEF1, but not for calcitonin-induced Erk1/2 phosphorylation. J Biol Chem. 2000 Nov 24; 275(47):37219-23. PMID: 10954702.
    View in: PubMed
  176. Sims NA, Clément-Lacroix P, Da Ponte F, Bouali Y, Binart N, Moriggl R, Goffin V, Coschigano K, Gaillard-Kelly M, Kopchick J, Baron R, Kelly PA. Bone homeostasis in growth hormone receptor-null mice is restored by IGF-I but independent of Stat5. J Clin Invest. 2000 Nov; 106(9):1095-103. PMID: 11067862; PMCID: PMC301420.
  177. Amling M, Neff L, Priemel M, Schilling AF, Rueger JM, Baron R. Progressive increase in bone mass and development of odontomas in aging osteopetrotic c-src-deficient mice. Bone. 2000 Nov; 27(5):603-10. PMID: 11062345.
    View in: PubMed
  178. Marzia M, Sims NA, Voit S, Migliaccio S, Taranta A, Bernardini S, Faraggiana T, Yoneda T, Mundy GR, Boyce BF, Baron R, Teti A. Decreased c-Src expression enhances osteoblast differentiation and bone formation. J Cell Biol. 2000 Oct 16; 151(2):311-20. PMID: 11038178; PMCID: PMC2192638.
  179. Sabatakos G, Sims NA, Chen J, Aoki K, Kelz MB, Amling M, Bouali Y, Mukhopadhyay K, Ford K, Nestler EJ, Baron R. Overexpression of DeltaFosB transcription factor(s) increases bone formation and inhibits adipogenesis. Nat Med. 2000 Sep; 6(9):985-90. PMID: 10973317.
    View in: PubMed
  180. Saini S, Sharma R, Baron RL, Turner DA, Ros PR, Hahn PF, Small WC, Delange EE, Stillman AE, Edelman RR, Runge VM, Outwater EK. Multicentre dose-ranging study on the efficacy of USPIO ferumoxtran-10 for liver MR imaging. Clin Radiol. 2000 Sep; 55(9):690-5. PMID: 10988047.
    View in: PubMed
  181. Ochoa GC, Slepnev VI, Neff L, Ringstad N, Takei K, Daniell L, Kim W, Cao H, McNiven M, Baron R, De Camilli P. A functional link between dynamin and the actin cytoskeleton at podosomes. J Cell Biol. 2000 Jul 24; 150(2):377-89. PMID: 10908579; PMCID: PMC2180219.
  182. Kawai S, Faucheu C, Gallea S, Spinella-Jaegle S, Atfi A, Baron R, Roman SR. Mouse smad8 phosphorylation downstream of BMP receptors ALK-2, ALK-3, and ALK-6 induces its association with Smad4 and transcriptional activity. Biochem Biophys Res Commun. 2000 May 19; 271(3):682-7. PMID: 10814522.
    View in: PubMed
  183. Delany AM, Amling M, Priemel M, Howe C, Baron R, Canalis E. Osteopenia and decreased bone formation in osteonectin-deficient mice J Clin Invest. 2000 May; 105(9):1325. PMID: 10792008.
    View in: PubMed
  184. Violette SM, Shakespeare WC, Bartlett C, Guan W, Smith JA, Rickles RJ, Bohacek RS, Holt DA, Baron R, Sawyer TK. A Src SH2 selective binding compound inhibits osteoclast-mediated resorption. Chem Biol. 2000 Mar; 7(3):225-35. PMID: 10712930.
    View in: PubMed
  185. Delaissé JM, Engsig MT, Everts V, del Carmen Ovejero M, Ferreras M, Lund L, Vu TH, Werb Z, Winding B, Lochter A, Karsdal MA, Troen T, Kirkegaard T, Lenhard T, Heegaard AM, Neff L, Baron R, Foged NT. Proteinases in bone resorption: obvious and less obvious roles. Clin Chim Acta. 2000 Feb 15; 291(2):223-34. PMID: 10675725.
    View in: PubMed
  186. Townsend PA, Villanova I, Uhlmann E, Peyman A, Knolle J, Baron R, Teti A, Horton MA. An antisense oligonucleotide targeting the alphaV integrin gene inhibits adhesion and induces apoptosis in breast cancer cells. Eur J Cancer. 2000 Feb; 36(3):397-409. PMID: 10708943.
    View in: PubMed
  187. Yokouchi M, Baron R, Yoshimura A. RING connection between ubiquitination and tumorigenesis. Experimental Medicine. 2000; 18:464-467.
  188. Sims NA, Baron R. Bone Cells and their Functions. Skeletal Growth Factors, E Canalis, Editor. 2000; Chpter 1:1-16.
  189. Riggs BL, Baron R, Boyle WJ, Drezner M, Manolagas S, Martin TJ, Stewart AF, Suda T, Yasuda H, Aubin J, Goltzman D. Proposed standard nomenclature for new tumor necrosis factor members involved in the regulation of bone resorption. Bone. 2000; 67:761-764.
  190. Villanova I, Townsend PA, Uhlmann E, Knolle J, Peyman A, Amling M, Baron R, Horton MA, Teti A. Oligodeoxynucleotide targeted to the alphav gene inhibits alphav integrin synthesis, impairs osteoclast function, and activates intracellular signals to apoptosis. J Bone Miner Res. 1999 Nov; 14(11):1867-79. PMID: 10571687.
    View in: PubMed
  191. Amling M, Priemel M, Holzmann T, Chapin K, Rueger JM, Baron R, Demay MB. Rescue of the skeletal phenotype of vitamin D receptor-ablated mice in the setting of normal mineral ion homeostasis: formal histomorphometric and biomechanical analyses. Endocrinology. 1999 Nov; 140(11):4982-7. PMID: 10537122.
    View in: PubMed
  192. Hernando N, David P, Tarsio M, Bartkiewicz M, Horne WC, Kane PM, Baron R. The presence of the alternatively spliced A2 cassette in the vacuolar H+-ATPase subunit A prevents assembly of the V1 catalytic domain. Eur J Biochem. 1999 Nov; 266(1):293-301. PMID: 10542077.
    View in: PubMed
  193. Amling M, Priemel M, Holzmann T, Chapin K, Rueger JM, Baron R, Demay MB. Rescue of the Skeletal Phenotype of Vitamin D Receptor-Ablated Mice in the Setting of Normal Mineral Ion Homeostasis: Formal Histomorphometric and Biomechanical Analyses1. Endocrinology. 1999 Nov 01; 140(11):4982-4987. PMID: 28200431.
    View in: PubMed
  194. Yokouchi M, Kondo T, Houghton A, Bartkiewicz M, Horne WC, Zhang H, Yoshimura A, Baron R. Ligand-induced ubiquitination of the epidermal growth factor receptor involves the interaction of the c-Cbl RING finger and UbcH7. J Biol Chem. 1999 Oct 29; 274(44):31707-12. PMID: 10531381.
    View in: PubMed
  195. Bartkiewicz M, Houghton A, Baron R. Leucine zipper-mediated homodimerization of the adaptor protein c-Cbl. A role in c-Cbl's tyrosine phosphorylation and its association with epidermal growth factor receptor. J Biol Chem. 1999 Oct 22; 274(43):30887-95. PMID: 10521482.
    View in: PubMed
  196. Aoki K, Didomenico E, Sims NA, Mukhopadhyay K, Neff L, Houghton A, Amling M, Levy JB, Horne WC, Baron R. The tyrosine phosphatase SHP-1 is a negative regulator of osteoclastogenesis and osteoclast resorbing activity: increased resorption and osteopenia in me(v)/me(v) mutant mice. Bone. 1999 Sep; 25(3):261-7. PMID: 10495129.
    View in: PubMed
  197. Zhang Z, Hernandez-Lagunas L, Horne WC, Baron R. Cytoskeleton-dependent tyrosine phosphorylation of the p130(Cas) family member HEF1 downstream of the G protein-coupled calcitonin receptor. Calcitonin induces the association of HEF1, paxillin, and focal adhesion kinase. J Biol Chem. 1999 Aug 27; 274(35):25093-8. PMID: 10455189.
    View in: PubMed
  198. Schecroun N, Pidoux E, Horne WC, Hernandez-Lagunas L, Baron R, Cressent M. Biological properties of salmon calcitonin IV. J Bone Miner Res. 1999 Aug; 14(8):1425-31. PMID: 10457276.
    View in: PubMed
  199. Lanske B, Amling M, Neff L, Guiducci J, Baron R, Kronenberg HM. Ablation of the PTHrP gene or the PTH/PTHrP receptor gene leads to distinct abnormalities in bone development. J Clin Invest. 1999 Aug; 104(4):399-407. PMID: 10449432; PMCID: PMC408525.
  200. Shyu JF, Zhang Z, Hernandez-Lagunas L, Camerino C, Chen Y, Inoue D, Baron R, Horne WC. Protein kinase C antagonizes pertussis-toxin-sensitive coupling of the calcitonin receptor to adenylyl cyclase. Eur J Biochem. 1999 May; 262(1):95-101. PMID: 10231369.
    View in: PubMed
  201. Inoue D, Shih C, Galson DL, Goldring SR, Horne WC, Baron R. Calcitonin-dependent down-regulation of the mouse C1a calcitonin receptor in cells of the osteoclast lineage involves a transcriptional mechanism. Endocrinology. 1999 Mar; 140(3):1060-8. PMID: 10067826.
    View in: PubMed
  202. Clément-Lacroix P, Ormandy C, Lepescheux L, Ammann P, Damotte D, Goffin V, Bouchard B, Amling M, Gaillard-Kelly M, Binart N, Baron R, Kelly PA. Osteoblasts are a new target for prolactin: analysis of bone formation in prolactin receptor knockout mice. Endocrinology. 1999 Jan; 140(1):96-105. PMID: 9886812.
    View in: PubMed
  203. Cle Ment-Lacroix P, Ormandy C, Lepescheux LN, Ammann P, Damotte D, Goffin V, Bouchard B, Amling M, Gaillard-Kelly M, Binart N, Baron R, Kelly PA. Osteoblasts Are a New Target for Prolactin: Analysis of Bone Formation in Prolactin Receptor Knockout Mice* *This work was supported in part by grants from Hoechst Marion Roussel, Inc. Endocrinology. 1999 Jan 01; 140(1):96-105. PMID: 28200601.
    View in: PubMed
  204. Corral DA, Amling M, Priemel M, Loyer E, Fuchs S, Ducy P, Baron R, Karsenty G. Dissociation between bone resorption and bone formation in osteopenic transgenic mice. Proc Natl Acad Sci U S A. 1998 Nov 10; 95(23):13835-40. PMID: 9811887; PMCID: PMC24916.
  205. David JP, Neff L, Chen Y, Rincon M, Horne WC, Baron R. A new method to isolate large numbers of rabbit osteoclasts and osteoclast-like cells: application to the characterization of serum response element binding proteins during osteoclast differentiation. J Bone Miner Res. 1998 Nov; 13(11):1730-8. PMID: 9797482.
    View in: PubMed
  206. Li YC, Amling M, Pirro AE, Priemel M, Meuse J, Baron R, Delling G, Demay MB. Normalization of mineral ion homeostasis by dietary means prevents hyperparathyroidism, rickets, and osteomalacia, but not alopecia in vitamin D receptor-ablated mice. Endocrinology. 1998 Oct; 139(10):4391-6. PMID: 9751523.
    View in: PubMed
  207. Li YC, Amling M, Pirro AE, Priemel M, Meuse J, Baron R, Delling G, Demay MB. Normalization of Mineral Ion Homeostasis by Dietary Means Prevents Hyperparathyroidism, Rickets, and Osteomalacia, But Not Alopecia in Vitamin D Receptor-Ablated Mice* * This work was supported by NIH Grants DK-46974 (to M.B.D.) and DE-04724 (to R.B.) and a NIH National Research Service Award (to Y.C.L.). Endocrinology. 1998 Oct 01; 139(10):4391-4396. PMID: 28200198.
    View in: PubMed
  208. Chen Y, Shyu JF, Santhanagopal A, Inoue D, David JP, Dixon SJ, Horne WC, Baron R. The calcitonin receptor stimulates Shc tyrosine phosphorylation and Erk1/2 activation. Involvement of Gi, protein kinase C, and calcium. J Biol Chem. 1998 Jul 31; 273(31):19809-16. PMID: 9677414.
    View in: PubMed
  209. Kelly KA, Tanaka S, Baron R, Gimble JM. Murine bone marrow stromally derived BMS2 adipocytes support differentiation and function of osteoclast-like cells in vitro. Endocrinology. 1998 Apr; 139(4):2092-101. PMID: 9528998.
    View in: PubMed
  210. Inoue D, Reid M, Lum L, Krätzschmar J, Weskamp G, Myung YM, Baron R, Blobel CP. Cloning and initial characterization of mouse meltrin beta and analysis of the expression of four metalloprotease-disintegrins in bone cells. J Biol Chem. 1998 Feb 13; 273(7):4180-7. PMID: 9461614.
    View in: PubMed
  211. Insogna KL, Sahni M, Grey AB, Tanaka S, Horne WC, Neff L, Mitnick M, Levy JB, Baron R. Colony-stimulating factor-1 induces cytoskeletal reorganization and c-src-dependent tyrosine phosphorylation of selected cellular proteins in rodent osteoclasts. J Clin Invest. 1997 Nov 15; 100(10):2476-85. PMID: 9366562; PMCID: PMC508448.
  212. Inoue D, Santiago P, Horne WC, Baron R. Identification of an osteoclast transcription factor that binds to the human T cell leukemia virus type I-long terminal repeat enhancer element. J Biol Chem. 1997 Oct 03; 272(40):25386-93. PMID: 9312160.
    View in: PubMed
  213. Li YC, Pirro AE, Amling M, Delling G, Baron R, Bronson R, Demay MB. Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia. Proc Natl Acad Sci U S A. 1997 Sep 02; 94(18):9831-5. PMID: 9275211; PMCID: PMC23277.
  214. Billecocq A, Horne WC, Chakraborty M, Takeyasu K, Levenson R, Baron R. 1,25-Dihydroxyvitamin D3 selectively induces increased expression of the Na,K-ATPase beta 1 subunit in avian myelomonocytic cells without a concomitant change in Na,K-ATPase activity. J Cell Physiol. 1997 Aug; 172(2):221-9. PMID: 9258343.
    View in: PubMed
  215. Amling M, Neff L, Tanaka S, Inoue D, Kuida K, Weir E, Philbrick WM, Broadus AE, Baron R. Bcl-2 lies downstream of parathyroid hormone-related peptide in a signaling pathway that regulates chondrocyte maturation during skeletal development. J Cell Biol. 1997 Jan 13; 136(1):205-13. PMID: 9008714; PMCID: PMC2132464.
  216. Insogna K, Tanaka S, Neff L, Horne W, Levy J, Baron R. Role of c-Src in cellular events associated with colony-stimulating factor-1-induced spreading in osteoclasts. Mol Reprod Dev. 1997 Jan; 46(1):104-8. PMID: 8981371.
    View in: PubMed
  217. Sahni M, Zhou XM, Bakiri L, Schlessinger J, Baron R, Levy JB. Identification of a novel 135-kDa Grb2-binding protein in osteoclasts. J Biol Chem. 1996 Dec 20; 271(51):33141-7. PMID: 8955163.
    View in: PubMed
  218. Shyu JF, Inoue D, Baron R, Horne WC. The deletion of 14 amino acids in the seventh transmembrane domain of a naturally occurring calcitonin receptor isoform alters ligand binding and selectively abolishes coupling to phospholipase C. J Biol Chem. 1996 Dec 06; 271(49):31127-34. PMID: 8940110.
    View in: PubMed
  219. Baron R. Molecular mechanisms of bone resorption: therapeutic implications. Rev Rhum Engl Ed. 1996 Nov; 63(10):633-8. PMID: 8953663.
    View in: PubMed
  220. Tanaka S, Amling M, Neff L, Peyman A, Uhlmann E, Levy JB, Baron R. c-Cbl is downstream of c-Src in a signalling pathway necessary for bone resorption. Nature. 1996 Oct 10; 383(6600):528-31. PMID: 8849724.
    View in: PubMed
  221. David P, Nguyen H, Barbier A, Baron R. The bisphosphonate tiludronate is a potent inhibitor of the osteoclast vacuolar H(+)-ATPase. J Bone Miner Res. 1996 Oct; 11(10):1498-507. PMID: 8889850.
    View in: PubMed
  222. Weir EC, Philbrick WM, Amling M, Neff LA, Baron R, Broadus AE. Targeted overexpression of parathyroid hormone-related peptide in chondrocytes causes chondrodysplasia and delayed endochondral bone formation. Proc Natl Acad Sci U S A. 1996 Sep 17; 93(19):10240-5. PMID: 8816783; PMCID: PMC38368.
  223. David P, Horne WC, Baron R. Vanadate inhibits vacuolar H(+)-ATPase-mediated proton transport in chicken kidney microsomes by an ADP-dependent mechanism. Biochim Biophys Acta. 1996 Apr 03; 1280(1):155-60. PMID: 8634310.
    View in: PubMed
  224. Levy JB, Schindler C, Raz R, Levy DE, Baron R, Horowitz MC. Activation of the JAK-STAT signal transduction pathway by oncostatin-M cultured human and mouse osteoblastic cells. Endocrinology. 1996 Apr; 137(4):1159-65. PMID: 8625884.
    View in: PubMed
  225. Tanaka S, Levy JB, Insogna KL. Baron R. c-Src: An essential gene for osteoclast function. Osteoporosis Japan. 1996; 4:62-67.
  226. Baron R. Molecular mechanisms of bone resorption. An update. Acta Orthop Scand Suppl. 1995 Oct; 266:66-70. PMID: 8553865.
    View in: PubMed
  227. Bartkiewicz M, Hernando N, Reddy SV, Roodman GD, Baron R. Characterization of the osteoclast vacuolar H(+)-ATPase B-subunit. Gene. 1995 Jul 28; 160(2):157-64. PMID: 7642089.
    View in: PubMed
  228. Hernando N, Bartkiewicz M, Collin-Osdoby P, Osdoby P, Baron R. Alternative splicing generates a second isoform of the catalytic A subunit of the vacuolar H(+)-ATPase. Proc Natl Acad Sci U S A. 1995 Jun 20; 92(13):6087-91. PMID: 7597085; PMCID: PMC41647.
  229. Tanaka S, Neff L, Baron R, Levy JB. Tyrosine phosphorylation and translocation of the c-cbl protein after activation of tyrosine kinase signaling pathways. J Biol Chem. 1995 Jun 16; 270(24):14347-51. PMID: 7782294.
    View in: PubMed
  230. Ravesloot JH, Eisen T, Baron R, Boron WF. Role of Na-H exchangers and vacuolar H+ pumps in intracellular pH regulation in neonatal rat osteoclasts. J Gen Physiol. 1995 Feb; 105(2):177-208. PMID: 7760016; PMCID: PMC2216940.
  231. David P, Baron R. The vacuolar H+ATPase: A potential target for drug development in bone diseases. Expert Opinion on Invest. Drugs. 1995; 4:725-740.
  232. Baron R,. Anatomy and ultrastructure of bone. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. 1995; 3-9.
  233. Baron R, Bartkiewicz M, David P Hernando-Sobrino N. Acidification and Bone Resorption: The Role and Characteristics of V-ATPases in the Osteoclast. Organellar Proton ATPases, Nelson N, Ed., Molecular biology Intelligence Series. 1995; 49-74.
  234. David P, Baron R. The catalytic cycle of the vacuolar H(+)-ATPase. Comparison of proton transport in kidney- and osteoclast-derived vesicles. J Biol Chem. 1994 Dec 02; 269(48):30158-63. PMID: 7982921.
    View in: PubMed
  235. Chakraborty M, Chatterjee D, Gorelick FS, Baron R. Cell cycle-dependent and kinase-specific regulation of the apical Na/H exchanger and the Na,K-ATPase in the kidney cell line LLC-PK1 by calcitonin. Proc Natl Acad Sci U S A. 1994 Mar 15; 91(6):2115-9. PMID: 8134357; PMCID: PMC43320.
  236. Baron R. The cellular basis of bone resorption: Cell biology of the osteoclast. Bone Formation and Repair, CT Brighton, GE Friedlaender, JM Lane, Eds. 1994; 247-252.
  237. Horowitz MC, Jay PR, Quian H-Y, baron R, Levy JB. Cytokine-induced signl transduction mediated by nonreceptor-tyrosine kinases in bone cells. Bone Formation and Repair, CT Brighton, GE Friedlaender, JM Lane, Eds. 1994; 269-278.
  238. Friedlaender GE, Troiano N, Ishii M, Pelker RR, Baron R. Abnormal bone remodeling: The consequences of the therapeutic drugs and physical modalities. Bone Formation and Repair, CT Brighton, GE Friedlaender, JM Lane, Eds. 1994; 289-297.
  239. Horne WC, Shyu JF, Chakraborty M, Baron R. Signal transduction by calcitonin: Multiple ligands, receptors and signaling pathways. Trends in Endocrinology. 1994; 5:395-401.
  240. Baron R, Bartkiewicz M, Chatterjee D, Chakrabort M, David P, Fabricant C, Hernando N. Characterization of the osteoclast vacuolar ATPase: Biochemistry, subunit composition and cloning of catalytic subunits. Molecular and Cellular Mechanisms of H+ Transport, NATO ASI Cell Biology Series, BH Hirst, Ed. 1994; 89:145-151.
  241. Weir EC, Horowitz MC, Baron R, Centrella M, Kacinski BM, Insogna KL. Macrophage colony-stimulating factor release and receptor expression in bone cells. J Bone Miner Res. 1993 Dec; 8(12):1507-18. PMID: 8304053.
    View in: PubMed
  242. Delaissé JM, Eeckhout Y, Neff L, François-Gillet C, Henriet P, Su Y, Vaes G, Baron R. (Pro)collagenase (matrix metalloproteinase-1) is present in rodent osteoclasts and in the underlying bone-resorbing compartment. J Cell Sci. 1993 Dec; 106 ( Pt 4):1071-82. PMID: 8126092.
    View in: PubMed
  243. Ruddle NH, Li CB, Horne WC, Santiago P, Troiano N, Jay G, Horowitz M, Baron R. Mice transgenic for HTLV-I LTR-tax exhibit tax expression in bone, skeletal alterations, and high bone turnover. Virology. 1993 Nov; 197(1):196-204. PMID: 8212554.
    View in: PubMed
  244. Chatterjee D, Neff L, Chakraborty M, Fabricant C, Baron R. Sensitivity to nitrate and other oxyanions further distinguishes the vanadate-sensitive osteoclast proton pump from other vacuolar H(+)-ATPases. Biochemistry. 1993 Mar 23; 32(11):2808-12. PMID: 8457547.
    View in: PubMed
  245. Horne WC, Levy JB, Baron R. Proto-oncogenes and osteoclast function. Italian J. of Min. and Electrolyte Metab. 1993; 7:185-197.
  246. Baron R. The molecular mechanisms of bone resorption. Proceedings of the 24th International Conf. on Osteoporosis, C Christiansen, B Riis, Eds. 1993; 258-260.
  247. Baron R, Chakraborty M, Chatterjee D, Horne WC, Lomri , Ravesloot J-H. Biology of the Osteoclast. Handbook of Experimental Pharmacology, Vol 107: Physiology and Pharmacology of Bone, GR Mundy, TJ Martin, Eds. 1993; Vol 107(Chapter 3):111-147.
  248. Baron R, Ravesloot J-H, Neff L, Chakraborty M, Chatterjee D, Lomri A, Horne WC. Cellular and Molecular Biology of the osteoclast. Cellular and Molecular Biology of Bone, M Noda, Ed. 1993; 446-495.
  249. Baron R, . Molecular Mechanisms and Regulation of Bone Resorption. Progress in Endocrinology, Mornex R, Jaffiol C, Lecleare J, Eds. 1993; 375-381.
  250. Horne WC, Neff L, Chatterjee D, Lomri A, Levy JB, Baron R. Osteoclasts express high levels of pp60c-src in association with intracellular membranes. J Cell Biol. 1992 Nov; 119(4):1003-13. PMID: 1385441; PMCID: PMC2289690.
  251. Chatterjee D, Chakraborty M, Leit M, Neff L, Jamsa-Kellokumpu S, Fuchs R, Bartkiewicz M, Hernando N, Baron R. The osteoclast proton pump differs in its pharmacology and catalytic subunits from other vacuolar H(+)-ATPases. J Exp Biol. 1992 Nov; 172:193-204. PMID: 1491225.
    View in: PubMed
  252. Su Y, Chakraborty M, Nathanson MH, Baron R. Differential effects of the 3',5'-cyclic adenosine monophosphate and protein kinase C pathways on the response of isolated rat osteoclasts to calcitonin. Endocrinology. 1992 Sep; 131(3):1497-502. PMID: 1324163.
    View in: PubMed
  253. Chatterjee D, Chakraborty M, Leit M, Neff L, Jamsa-Kellokumpu S, Fuchs R, Baron R. Sensitivity to vanadate and isoforms of subunits A and B distinguish the osteoclast proton pump from other vacuolar H+ ATPases. Proc Natl Acad Sci U S A. 1992 Jul 15; 89(14):6257-61. PMID: 1385872; PMCID: PMC49479.
  254. Lomri A, Baron R. 1 alpha,25-dihydroxyvitamin D3 regulates the transcription of carbonic anhydrase II mRNA in avian myelomonocytes. Proc Natl Acad Sci U S A. 1992 May 15; 89(10):4688-92. PMID: 1584805; PMCID: PMC49148.
  255. Prallet B, Male P, Neff L, Baron R. Identification of a functional mononuclear precursor of the osteoclast in chicken medullary bone marrow cultures. J Bone Miner Res. 1992 Apr; 7(4):405-14. PMID: 1376957.
    View in: PubMed
  256. Delaisse JM, Neff L, Eeckhout Y, Su Y, Vaes G, Baron R. Evidence for the presence of (ro) collagenase in osteoclasts. Calcium Regulation and Bone Metabolism, Cohn DV, Gennari C, Tashjian AH, Eds. 1992; 161-164.
  257. Baron R, Bartkiewicz M, Chakraborty M, Chatterjee D, Fabricant C, Hernando N, Horne WC, Lomri A, Neff L, Ravesloot JH, Su Y. Ion transport and the molecular mechanisms of bone resorption. Calcium Regulation and Bone Metabolism, Cohn DV, Gennari C, Tashjian AH, Eds. 1992; 131-141.
  258. Prallet B, Alexandre C, Baron R. [In vitro identification of a mononuclear precursor of osteoclast]. Rev Rhum Mal Osteoartic. 1991 Nov 30; 58(11):777-80. PMID: 1780653.
    View in: PubMed
  259. Chakraborty M, Chatterjee D, Kellokumpu S, Rasmussen H, Baron R. Cell cycle-dependent coupling of the calcitonin receptor to different G proteins. Science. 1991 Mar 01; 251(4997):1078-82. PMID: 1847755.
    View in: PubMed
  260. Baron R, Neff L, Brown W, Louvard D, Courtoy PJ. Selective internalization of the apical plasma membrane and rapid redistribution of lysosomal enzymes and mannose 6-phosphate receptors during osteoclast inactivation by calcitonin. J Cell Sci. 1990 Nov; 97 ( Pt 3):439-47. PMID: 1963625.
    View in: PubMed
  261. Billecocq A, Emanuel JR, Levenson R, Baron R. 1 alpha,25-dihydroxyvitamin D3 regulates the expression of carbonic anhydrase II in nonerythroid avian bone marrow cells. Proc Natl Acad Sci U S A. 1990 Aug; 87(16):6470-4. PMID: 2166957; PMCID: PMC54556.
  262. Lindsey AE, Schneider K, Simmons DM, Baron R, Lee BS, Kopito RR. Functional expression and subcellular localization of an anion exchanger cloned from choroid plexus. Proc Natl Acad Sci U S A. 1990 Jul; 87(14):5278-82. PMID: 2371270; PMCID: PMC54306.
  263. Billecocq A. Rettig-Emanuel J, Levenson R, Baron R. l alpha,25-Dihydroxyvitamin D3 regulates the expression of carbonic anhydrase II n nonerythroid avain bone marrow cells. Proc. nat. Acad. Sci. USA. 1990; 87:6470-6474.
  264. Prallet B, Male P, Neff L, Billecocq A, Baron R. late mononuclear osteoclast precursors resorb bone in vitro. Calcium Regulation and Bone Metabolism, DV Cohn, FH Glorieux, TJ Martin, Eds. 1990; 434-438.
  265. Chen C, Carpenter T, Steg N, Baron R, Anast C. Hypercalciuric hypophosphatemic rickets, mineral balance, bone histomorphometry, and therapeutic implications of hypercalciuria. Pediatrics. 1989 Aug; 84(2):276-80. PMID: 2787497.
    View in: PubMed
  266. Baron R. Molecular mechanisms of bone resorption by the osteoclast. Anat Rec. 1989 Jun; 224(2):317-24. PMID: 2549811.
    View in: PubMed
  267. Baron R, Prallet B. Les Bases Cellulaires de l'Homeostasie du Squelette. Medicine and Hygiene. 1989; 47:825-828.
  268. Baron R. Polarity and membrane transport in osteoclasts. Connect Tissue Res. 1989; 20(1-4):109-20. PMID: 2692952.
    View in: PubMed
  269. Thomas HA, Machen TE, Smolka A, Baron R, Kopito RR. Anion exchanger-related peptides and (H,K)ATPase are present on opposite membranes of the same gastric mucosal oxntic cells. Am J Physiol. 1989; 257:C537-C544.
  270. Kellokumpu S, Neff L, Jämsä-Kellokumpu S, Kopito R, Baron R. A 115-kD polypeptide immunologically related to erythrocyte band 3 is present in Golgi membranes. Science. 1988 Dec 02; 242(4883):1308-11. PMID: 2461589.
    View in: PubMed
  271. Rubin KR, Ballow M, Baron R, Greenstein RM, Raisz LG, Rowe DW. Malignant osteoporosis and defective immunoregulation. J Bone Miner Res. 1988 Oct; 3(5):509-16. PMID: 3195363.
    View in: PubMed
  272. Baron R, Neff L, Brown W, Courtoy PJ, Louvard D, Farquhar MG. Polarized secretion of lysosomal enzymes: co-distribution of cation-independent mannose-6-phosphate receptors and lysosomal enzymes along the osteoclast exocytic pathway. J Cell Biol. 1988 Jun; 106(6):1863-72. PMID: 2968345; PMCID: PMC2115156.
  273. Key LL, Volberg F, Baron R, Anast CS. Treatment of craniometaphyseal dysplasia with calcitriol. J Pediatr. 1988 Apr; 112(4):583-7. PMID: 3351684.
    View in: PubMed
  274. de Vernejoul MC, Horowitz M, Demignon J, Neff L, Baron R. Bone resorption by isolated chick osteoclasts in culture is stimulated by murine spleen cell supernatant fluids (osteoclast-activating factor) and inhibited by calcitonin and prostaglandin E2. J Bone Miner Res. 1988 Feb; 3(1):69-80. PMID: 3264994.
    View in: PubMed
  275. Jaeger P, Jones W, Kashgarian M, Baron R, Clemens TL, Segre GV, Hayslett JP. Animal model of primary hyperparathyroidism. Am J Physiol. 1987 Jun; 252(6 Pt 1):E790-8. PMID: 3591940.
    View in: PubMed
  276. Dyess CL, Carter D, Kirchner JA, Baron RE. A morphometric comparison of the changes in the laryngeal skeleton associated with invasion by tumor and by external-beam radiation. Cancer. 1987 Mar 15; 59(6):1117-22. PMID: 3815286.
    View in: PubMed
  277. Marie P, Alexandre C, Chappard D, Berthel M, Jensen P, Baron R, Caulin F. Postmenopausal osteoporosis treated with phosphate and intermittent calcitonin. Osteoporosis, C. Christiansen, JS Johansen, BJ Riss, Eds. 1987; 936-941.
  278. Marie P, Alexandre C, Chappard D, Berthel M, Jensen P, Lange R, Baron R, Caulin F. Rationale of using sequential treatment with phosphate and calcitonin in postmenopausal osteoporosis. Calcium Regulation and Bone Metabolism: Basic and Clinical Aspects, Cohn DV, Martin TJ, Meunier PJ, Eds. 1987; 943-947.
  279. De Luca J, Cianelli C, Friedlaender GE, Baron R. A comparative histomorphometric study of bone remodeling in human paired cancellous allografts and autografts. Trans. Orthop. Res. Soc. 1987; 12:356.
  280. Baron R, Neff L, Roy C, Boisvert A, Caplan M. Evidence for a high and specific concentration of (Na+,K+)ATPase in the plasma membrane of the osteoclast. Cell. 1986 Jul 18; 46(2):311-20. PMID: 2424614.
    View in: PubMed
  281. Baron R, Neff L, Tran Van P, Nefussi JR, Vignery A. Kinetic and cytochemical identification of osteoclast precursors and their differentiation into multinucleated osteoclasts. Am J Pathol. 1986 Feb; 122(2):363-78. PMID: 3946557; PMCID: PMC1888102.
  282. Baron R. [The cellular base of adult bone remodelling]. Orthod Fr. 1986; 57 Pt 2:371-7. PMID: 3077149.
    View in: PubMed
  283. Baron R, Neff L, Louvard D, Courtoy PJ. Cell-mediated extracellular acidification and bone resorption: evidence for a low pH in resorbing lacunae and localization of a 100-kD lysosomal membrane protein at the osteoclast ruffled border. J Cell Biol. 1985 Dec; 101(6):2210-22. PMID: 3905822; PMCID: PMC2114017.
  284. Nefussi JR, Baron R. PGE2 stimulates both resorption and formation of bone in vitro: differential responses of the periosteum and the endosteum in fetal rat long bone cultures. Anat Rec. 1985 Jan; 211(1):9-16. PMID: 3985383.
    View in: PubMed
  285. Horowitz M, Baron R, Mart J, Andreoli M, Vignery A. Osteoclast Activating Factor is distinct from the monokine Interleukin-1. Br. J. Rheumatol. 1985; 24(suppl 1):162-164.
  286. Gkonos PJ, Hayes T, Burtis W, Jacoby R, McGuire J, Baron R, Stewart AF. Squamous carcinoma model of humoral hypercalcemia of malignancy. Endocrinology. 1984 Dec; 115(6):2384-90. PMID: 6499773.
    View in: PubMed
  287. Godsall JW, Baron R, Insogna KL. Vitamin D metabolism and bone histomorphometry in a patient with antacid-induced osteomalacia. Am J Med. 1984 Oct; 77(4):747-50. PMID: 6486152.
    View in: PubMed
  288. Horowitz M, Vignery A, Gershon RK, Baron R. Thymus-derived lymphocytes and their interactions with macrophages are required for the production of osteoclast-activating factor in the mouse. Proc Natl Acad Sci U S A. 1984 Apr; 81(7):2181-5. PMID: 6609360; PMCID: PMC345461.
  289. Friedlaender GE, Tross RB, Doganis AC, Kirkwood JM, Baron R. Effects of chemotherapeutic agents on bone. I. Short-term methotrexate and doxorubicin (adriamycin) treatment in a rat model. J Bone Joint Surg Am. 1984 Apr; 66(4):602-7. PMID: 6707039.
    View in: PubMed
  290. Insogna KL, Stewart AF, Vignery AM, Weir EC, Namnum PA, Baron RE, Kirkwood JM, Deftos LM, Broadus AE. Biochemical and histomorphometric characterization of a rat model for humoral hypercalcemia of malignancy. Endocrinology. 1984 Mar; 114(3):888-96. PMID: 6546543.
    View in: PubMed
  291. Baron R, Tross R, Vignery A. Evidence of sequential remodeling in rat trabecular bone: morphology, dynamic histomorphometry, and changes during skeletal maturation. Anat Rec. 1984 Jan; 208(1):137-45. PMID: 6711834.
    View in: PubMed
  292. Friedlander GE, Baron R, Pelker RR, Doganis AC. The effects of chemotherapy and radiation therapy on physiologic bone turnover and fracture repair. Soft and Hard Tissue, TK Hunt, RB Heppenstall, E Pines, D Rovee, Eds. 1984; 397-416.
  293. Baron R, Vignery A, Horowitz M. Lymphocytes, macrophages and the regulation of bone remodeling. Advances in Bone and Mineral Research, Annual, HWA Peck, Ed. 1984; 175-243.
  294. Guedon C, de Vernejoul MC, Gehanno P, Baron R, Soussaline M. [Biological aspects of bone grafts and vascularized bone transfer]. Ann Chir Plast Esthet. 1984; 29(4):322-8. PMID: 6084442.
    View in: PubMed
  295. Jaeger P, Jones W, Baron R, Hayslett JP. Modulation of hypercalcemia by dichloromethane diphosphonate and by calcitonin in a model of chronic primary hyperparathyroidism in rats. Prog Clin Biol Res. 1984; 168:375-80. PMID: 6240064.
    View in: PubMed
  296. Baron R, Mage S, Silverglate A, Broadus A, Lang R. Estimation of trabecular bone resorption by histomorpometry: Evidence for a prolonged reversal phase with normal resorption in post-menopausal osteoporosis and coupled increased resorption in primary hyperparathyroidism. Clinical Disorders of Bone and Mineral Metabolism, Frame B and Potts J, Eds. 1984; 191-195.
  297. Broadus AE, Magee JS, Mallette LE, Horst RL, Lang R, Jensen PS, Gertner JM, Baron R. A detailed evaluation of oral phosphate therapy in selected patients with primary hyperparathyroidism. J Clin Endocrinol Metab. 1983 May; 56(5):953-61. PMID: 6300178.
    View in: PubMed
  298. Simmons DJ, Russell JE, Winter F, Tran Van P, Vignery A, Baron R, Rosenberg GD, Walker WV. Effect of spaceflight on the non-weight-bearing bones of rat skeleton. Am J Physiol. 1983 Mar; 244(3):R319-26. PMID: 6829791.
    View in: PubMed
  299. Baron R, Gertner JM, Lang R, Vignery A. Increased bone turnover with decreased bone formation by osteoblasts in children with osteogenesis imperfecta tarda. Pediatr Res. 1983 Mar; 17(3):204-7. PMID: 6835724.
    View in: PubMed
  300. Baron R, Vignery A, Neff L, Silverglate A, Santa Maria A. Processing of undecalcified bone specimens for bone histomorphometry. Bone Histomorphometry: Techniques and Interpretation, R.R. Recker Ed. 1983; 13-35.
  301. Friedlaender GE, Baron R, Pelker RR. Effects of Chemotherapy on Bone. Osteochondrial Allografts. Biology, Banking and Clinical Applications, Friedlaender, GE, Mankin HJ, Sell KW, Eds. 1983; 319-327.
  302. Nefussi JR, Vignery A, Puzas JE, Baron R. Histomorphometry and autoradiography of cultured fetal rat long bones. Anat Rec. 1982 Oct; 204(2):105-12. PMID: 7181126.
    View in: PubMed
  303. Stewart AF, Vignery A, Silverglate A, Ravin ND, LiVolsi V, Broadus AE, Baron R. Quantitative bone histomorphometry in humoral hypercalcemia of malignancy: uncoupling of bone cell activity. J Clin Endocrinol Metab. 1982 Aug; 55(2):219-27. PMID: 7085851.
    View in: PubMed
  304. Tran Van PT, Vignery A, Baron R. Cellular kinetics of the bone remodeling sequence in the rat. Anat Rec. 1982 Apr; 202(4):445-51. PMID: 7072987.
    View in: PubMed
  305. Tran Van P, Vignery A, Baron R. An electron-microscopic study of the bone-remodeling sequence in the rat. Cell Tissue Res. 1982; 225(2):283-92. PMID: 7105150.
    View in: PubMed
  306. Baron R, Mazur A, Norman M. Histomorphometric classification of juvenile renal osteodystrophy: Prevalence of a mineralization defect. Vitamin D, A.W. Norman et al, Eds. 1982; 853-855.
  307. Baron R, Tran Van P, Vignery A. Local control of bone remodeling: A suggested role for receptor-mediated endocytosis. Current Advances in Skeletogenesis, M. Silbermann and H. Slavkin, Eds. 1982; 123-127.
  308. Rasmussen H, Mazur A, Pechet M, Gertner J, Baron R, Anast C. Treatment of familial hypophosphatemic rickets. Vitamin D, A.W. Norman et al, Eds. 1982; 1219-1225.
  309. Langman C B, Mazur A T, Baron R, Norman M E. 25-hydroxyvitamin D3 (calcifediol) therapy of juvenile renal osteodystrophy: Beneficial effect on linear growth velocity. J. Peds. 1982; 100:815-820.
  310. Baron R, Vignery A. Behavior of the osteoclasts during a rapid change in their number induced by high doses of parathyroid hormone or calcitonin in intact rats. . Metab. Bone Dis. Rel. Res. 1981; 2:339-346.
  311. Simmons DJ, Russell JE, Winter F, Baron R, Vignery A, Tran VT, Rosenberg GD, Walker W. Bone growth in the rat mandible during space flight. Physiologist. 1980 Dec; 23(Suppl 6):S87-90. PMID: 7243947.
    View in: PubMed
  312. Rasmussen H, Baron R, Broadus A, DeFronzo R, Lang R, Horst R. 1,25(OH)2D3 is not the only D metabolite involved in the pathogenesis of osteomalacia. Am J Med. 1980 Sep; 69(3):360-8. PMID: 6251721.
    View in: PubMed
  313. Norman ME, Mazur AT, Borden S, Gruskin A, Anast C, Baron R, Rasmussen H. Early diagnosis of juvenile renal osteodystrophy. J Pediatr. 1980 Aug; 97(2):226-32. PMID: 7400889.
    View in: PubMed
  314. Vignery A, Baron R. Dynamic histomorphometry of alveolar bone remodeling in the adult rat. Anat Rec. 1980 Feb; 196(2):191-200. PMID: 7416512.
    View in: PubMed
  315. Jensen PS, Orphanoudakis SC, Rauschkolb EN, Baron R, Lang R, Rasmussen H. Assessment of bone mass in the radius by computed tomography. AJR Am J Roentgenol. 1980 Feb; 134(2):285-92. PMID: 6766235.
    View in: PubMed
  316. Delling G, Luehmann M, Baron R, Mathews CHE, Olah A. Investigation of intra-and inter-reader reproducibility. Bone Histomorphometry, A.M. Parfitt and W.S.S. Jee, Eds. Suppl. to Metab. Bone Dis. Rel. Res. 1980; 2S:419-427.
  317. Baron R, Vignery A, Lang R. Reversal phase and osteoporosis: Defective coupling of resorption to formationn of pathogenesis of osteoporosis. Osteoporosis: Recent Advances in Pathogenesis and Treatment, H.F. DeLuca, Ed. 1980; 311-320.
  318. Canalis E, Reardon G E, Baron R, Raisz L G. Dynamic bone morphometry and studies on the effects of serum on bone metabolism in vitro in a case of pycnodysostosis. Metab. Bone Dis. Rel. Res. 1980; 2:99-106.
  319. Baron R, Vignery A, Tran Van P. The significance of lacunar erosion without osteoclasts: Studies on the reversal phase of the remodeling sequence. Bone Histomorphometry, A.M. Parfitt, W.S.S. Jee, Eds., Suppl. to Metab. Bone Dis. Res. 1980; 2S:35-40.
  320. Baron R, Vignery A, Lang R, LiVolsi V, Broadus A. Reversal lacunae and resporption-formation coupling: A histomorphometric comparison between osteopenia and hyperparathyroidism. Osteoporosis, H. Rasmussen, Ed. 1980; 141-149.
  321. Vignery A, Baron R. Comparative effects of APD and C12MDP on bone in the rat: In vivo and In vitro studies. Bone Histomorphometry, A.M. Parfitt and W.S.S. Jee Eds., Suppl. to Metab. Bone Dis. Rel. Res. 1980; 2S:381-387.
  322. Baron R, Norman M, Mazur A, Gruskin A, Rasmussen H. Bone histomorphometry in children with early chronic renal failure treated with 25(OH)D3. Vitamin D, Basic Research and Its Clinical Application, AW Norman, K Schaefer, DV Herrath, HG Grigoleit, JW Coburn, HF DeLuca, EB Mauer, T Suda, Eds. 1979; 847-850.
  323. Baron R, Gertner J, Lang R, Vignery A . Dynamic histomorphometry of trabecular bone in children with osteogenesis imperfecta. Trans. Orthop. Res. Soc. 1979; 4:107.
  324. Tross R B, Friedlaender G E, Baron R, Panjabi M. The effect of chemotherapy on bone volume and strength. Trans. Orthop. Res. Soc. 1979; 4:262.
  325. Vignery A, Baron R. Effects of parathyroid hormone on the osteoclastic pool, bone resorption and formation in rat alveolar bone. Calcif Tissue Res. 1978 Nov 10; 26(1):23-8. PMID: 737549.
    View in: PubMed
  326. Baron R, Saffar JL. A quantitative study of bone remodeling during experimental periodontal disease in the golden hamster. J Periodontal Res. 1978 Jul; 13(4):309-15. PMID: 149850.
    View in: PubMed
  327. Saffar JL, Baron R. A quantitative study of osteoclastic bone resorption during experimental periodontal disease in the golden hamster. J Periodontal Res. 1977 Sep; 12(5):387-94. PMID: 143521.
    View in: PubMed
  328. Baron R, Saffar JL, Duflot-Vignery A. Alveolar bone remodelling in the rat: normal status and effects of PTX and PTH on the remodelling sequence and the osteoclastic pool. Calcif Tissue Res. 1977 May; 22 Suppl:502-4. PMID: 912575.
    View in: PubMed
  329. Baron R, Saffar JL. A quantitative study of the effects of prolonged calcitonin treatment on alveolar bone remodelling in the golden hamster. Calcif Tissue Res. 1977 Feb 11; 22(3):265-74. PMID: 843968.
    View in: PubMed
  330. Baron R. [Changes in alveolar bone during spontaneous and induced tooth movement]. Mondo Ortod. 1977 Feb-Mar; 19(1):29-44. PMID: 275546.
    View in: PubMed
  331. Baron R. Importance of the intermediate phases between resorption and formation in the measurement and understanding of the bone remodeling sequence. Bone Histomorphometry, P.J. Meunier, Ed. 1977; 1977.
  332. Baron R. Osteogenese et fonction osteoblastique dans le maintien de la masse osseuse. Entretiens de Bichat. Odonto-Stomatologie, L'Expansion Scientifique, Ed. 1976; 27-32.
  333. Baron R, Saffar J-L, Kaleka R. Etude histometrique des effects de la calcitonine sur la pathologies observee au cours des parodontopathies experimentales chez le hamster dore. L'Information Dentaire. 1976; 48:103-112.
  334. Baron R, Vignery A. Changes in the osteoclastic pools and the osteoclasts nuclei balance after a single injection of salmon calcitonin in the adult rat. Bone Histomorphometry, P.J. Meunier, Ed. 1976; 147-156.
  335. Baron R. [Remodeling of alveolar bone in spontaneous and induced tooth displacement]. Rev Orthop Dento Faciale. 1975 Jul; 9(3):309-25. PMID: 1078137.
    View in: PubMed
  336. Mailland M, Baron R. [Quantitative study of the effects of occlusal overload on interradicular bone density in the rat]. J Biol Buccale. 1975 Mar; 3(1):41-51. PMID: 1058181.
    View in: PubMed
  337. Baron R. [Changes in alveolar bone in spontaneous or completed dental movement]. Inf Orthod Kieferorthop. 1975; 7(3):241-59. PMID: 1076335.
    View in: PubMed
  338. Baron R. Histophysiologie des reactions tissulaires au cours du deplacement orthodontique. Bases Fondamentales de l'ODF, M Chateau, Ed. 1975; 328-364.
  339. Drouet J, Deloince R, Baron R. Etude ultrastructurale de la reaction periostee au cours des fractures diaphysaires chez des souris exposees a une irradiation X. Medecine et Armees. 1974; 2:427-436.
  340. Baron R. Histologie et physiologie de al lame cribriforme. Entretiens de Bichat. Ondonto-Stomatologie, L'Expansion Scientifique Ed. 1973; 7-15.
  341. Baron R. Ultrastructure de l'os fascicule et des fibres de Sharpey de la lame cribriforme. J. Biol. Buccale. 1973; 1:201-213.
  342. Deloince R, Baron R, Drouet J. Ultrastructure de la reaction periostee apres fracture chez la souris. I. Les differents type cellulaires. Bull. Ann. CRSSA. 1973; 103-105.
  343. Baron R. Analyse de la conservation des vestiges dentaires dans les sepultures collectives. L'Homme, Hier et Aujourd'hui. Receuil d'etudes en Hommage a Andre Leroi-Gourhan. 1973; 295-305.
  344. Drouet J, Baron R, Deloince R. Ultrastructure de la reaction periostee apres fracture chez la souris. II. Formation et mineralisation du tissue osteoide. Bull. Ann. CRSSA. 1973; 106-108.
  345. Drouet J, Baron R, Deloince R. Etude ultrastructurale des effects d'une irradiation sur la reaction periostee apres fracture chez la souris. Bull. Ann. CRSSA. 1973; 43-45.
  346. Markostamou K, Baron R. [Quantitative study of osteoclasia of the alveolar ridge in experimental orthodontics in rats]. Orthod Fr. 1973; 44(1):245-58. PMID: 4534419.
    View in: PubMed
  347. Baron R. Remaniement de la lame cribriforme et des fibres desmodontales au cours de la migration physiologique. J. Biol. Buccale. 1973; 1:151-171.
  348. Baron R., Le Jeune M, Klapisz-Wolikow M. Aspects miscroscopiques des surfaces d'usure et mouvements mandibulaires. Etude prelimninaire sur quelques mammiferes. Sci. Rech. Odontostom. 1972; 2:25-31.
  349. Baron R, Mailland M, Lai Son OH. Les transplantations sous-cutanees de germes dentaires dans le cadre de l'etude de l'os alveolaire. ConreAngle. 1972; 2:7576.
  350. Lai HO, Baron R, Mailland M. [Statistical study of the incidence of dental caries and missing teeth in some neolithic populations of the Paris basin]. Rev Fr Odontostomatol. 1970 Oct; 17(8):1063-80. PMID: 4395819.
    View in: PubMed
  351. Juster M, Hess JC, Baron R. [Microradiography and dentistry]. Rev Fr Odontostomatol. 1970 Aug-Sep; 17(7):917-26. PMID: 5274270.
    View in: PubMed
  352. Baron R, Balmain-Oligo N. [The cribriform lamina in the rat. A microradiographic and historical survey]. Actual Odontostomatol (Paris). 1970 Jun; 90:183-98. PMID: 5424122.
    View in: PubMed
  353. Baron R. Etude odontologique de la population neolithique des incinerations de Neuvy-en-Dunois. Gallia Prehistoire (CNRS) XI. 1968; 224-231.
  354. Baron R, Monimignaut C. Etude odontologique de la population neolithique de la epulture collective de marolles sur Seine. Gallia Prehistoire (CNRS) X. 1967; 141-155.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Baron's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (974)
Explore
_
Co-Authors (65)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Tool Page Footer - Harvard Catalyst Tool Page Footer – Harvard Catalyst
Funded by the NIH/NCATS Clinical and Translational Science Award (CTSA) program, grant number UL1TR001102, and through institutional support from Harvard University, Harvard Medical School, Harvard T.H. Chan School of Public Health, Beth Israel Deaconess Medical Center, Boston Children's Hospital, Brigham and Women's Hospital, Massachusetts General Hospital and the Dana Farber Cancer Institute.